This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Interstitial lung disease
ILD
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5925 |
4. Check minimum number of eventsNone |
5925 |
5. Include endpointsNone |
5925 |
6. Filter based on genotype QC (FinnGen only) |
5925 |
Control definitions (FinnGen only)
- Control exclude
- ILD_ENDPOINTS
Extra metadata
- First used in FinnGen datafreeze
- DF6
- Parent code in ICD-10
- J80-J84
- Name in latin
- Alii morbi interstitiales pulmonum
Similar endpoints
↥List of similar endpoints to
Interstitial lung disease
based on the number of shared cases.
Similar with more cases:
- Other interstitial pulmonary diseases
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
- Diseases of the respiratory system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5925 | 2347 | 3578 |
| Unadjusted period prevalence (%) | 1.27 | 0.80 | 1.58 |
| Median age at first event (years) | 69.42 | 66.87 | 71.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5266
- Matched controls
- 52659
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
467
*
H02AB06
ATC
prednisolone; systemic
5.2
323.0
3854
18028
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.6
323.0
1827
2508
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
323.0
1440
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
323.0
3455
18344
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
20.0
323.0
994
606
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8746.3
323.0
2752
6
TGC00
NOMESCO Finland
Bronchial lavation
34.5
323.0
1178
436
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
323.0
389
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
15369.2
323.0
2518
*
XG410
NOMESCO Finland
Flow-volume spirometry
9.4
323.0
786
965
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
323.0
2636
10122
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
25.2
323.0
1795
1058
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.2
323.0
1892
3379
L04AX05
ATC
pirfenidone; oral
+∞
321.1
305
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.7
302.9
1185
3066
R06.0
ICD-10 Finland
Dyspnoea
3.2
302.3
2143
9204
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.6
298.5
842
1482
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
9.8
264.3
565
641
R03AC02
ATC
salbutamol; inhalant
2.7
256.8
3125
18382
L04AX01
ATC
azathioprine; systemic
8.2
249.8
595
808
GD1AD
NOMESCO Finland
Thorax CT examination
7.0
246.5
655
1047
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
216.6
2332
12331
L01XE31
ATC
[U] nintedanib; oral
+∞
205.5
196
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
77.3
201.5
229
31
J96.1
ICD-10 Finland
Chronic respiratory failure
8.9
200.5
450
548
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
200.2
705
1578
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
195.6
817
2172
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
26.5
193.1
272
108
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.1
190.1
658
1441
L04AA06
ATC
mycophenolic acid; systemic
13.2
174.9
317
254
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
39.0
169.7
217
58
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
168.6
161
*
J01MA14
ATC
moxifloxacin; systemic
3.7
166.6
832
2564
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
165.0
914
3055
48499
ICD-8 Finland
Acute interstitial pneumonia
+∞
150.7
144
*
R03BB04
ATC
tiotropium bromide; inhalant
3.0
147.2
976
3685
P01BA02
ATC
hydroxychloroquine; oral
3.8
145.5
683
1983
A02BC02
ATC
pantoprazole; systemic
2.2
144.2
3663
27028
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
137.6
537
1313
L01EX09
ATC
nintedanib; oral
+∞
136.0
130
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.1
125.9
529
1384
R05
ICD-10 Finland
Cough
2.4
123.4
1245
5954
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.3
122.1
342
571
C03CA01
ATC
furosemide; systemic
2.0
118.4
2215
13933
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
118.1
113
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
114.0
1194
5787
Z94.2
ICD-10 Finland
Lung transplant status
135.2
111.5
119
9
M05BA04
ATC
alendronic acid; oral
3.0
111.3
720
2632
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
110.9
1162
5621
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.7
110.9
405
920
GDG10
NOMESCO Finland
Bilateral transplantation of lung
371.6
109.7
110
*
J01MA12
ATC
levofloxacin; systemic
2.1
96.5
1284
6882
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
10.3
91.5
186
187
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
91.4
889
4096
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
88.9
1078
5517
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
434.6
86.3
86
*
J47
ICD-10 Finland
Bronchiectasis
6.4
85.9
237
386
R4110
NOMESCO Finland
Physiotherapy
1.9
84.2
1521
9128
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
84.1
1421
8317
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
83.5
300
667
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
83.4
690
2901
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.8
83.1
595
2297
J01AA02
ATC
doxycycline; systemic
1.9
82.4
4007
33210
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
10.5
81.5
163
159
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
79.7
540
2011
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
77.5
469
1619
J43.9
ICD-10 Finland
Emphysema, unspecified
6.1
77.5
220
372
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
76.4
453
1542
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
76.3
1208
6855
R03BA08
ATC
ciclesonide; inhalant
2.9
75.7
497
1811
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
75.1
1261
7308
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
74.4
2397
17225
R02
ICPC
Shortness of breath/dyspnoea
2.3
74.0
790
3776
R04.2
ICD-10 Finland
Haemoptysis
3.8
72.4
329
911
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
72.1
1097
6109
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
71.9
1677
10870
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
8.3
71.4
163
201
R50.9
ICD-10 Finland
Fever, unspecified
2.2
71.0
861
4357
J01FA06
ATC
roxithromycin; oral
1.7
70.0
2057
14296
L04AA13
ATC
leflunomide; oral
5.2
69.0
223
441
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
68.2
872
4510
WX892
NOMESCO Finland
Monitored bed care
2.6
67.9
561
2343
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.8
67.7
307
848
XG466
NOMESCO Finland
Sleep oxymetry
3.9
65.1
286
768
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
63.8
1168
6922
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
63.6
456
1749
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
62.0
1101
6448
L04AD01
ATC
ciclosporin; systemic
6.0
60.3
173
297
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.5
60.0
186
351
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.3
59.6
90
45
R03AK08
ATC
formoterol and beclometasone; inhalant
3.7
59.6
272
754
H02AB07
ATC
prednisone; oral
2.0
58.4
864
4709
WW200
NOMESCO Finland
Immunization
4.4
57.8
219
513
Z3226
NOMESCO Finland
Physiotherapist
1.9
57.1
1037
6096
XX4BW
NOMESCO Finland
NA
40.0
56.4
71
18
127
Kela drug reimbursment
Transplant complication
6.7
56.3
148
226
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.5
55.5
170
316
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
55.3
417
1645
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
5.5
54.8
168
313
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.1
54.8
326
1107
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
54.1
1421
9380
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
53.6
950
5521
R03AK07
ATC
formoterol and budesonide; inhalant
1.9
52.7
914
5269
J01CA04
ATC
amoxicillin; systemic
1.6
52.6
3782
32242
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.8
52.6
232
625
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
52.4
481
2110
R05
ICPC
Cough
1.8
52.0
1091
6704
ZXE00
NOMESCO Finland
One hour or less
1.6
51.9
1991
14528
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.4
51.5
126
174
ZX120
NOMESCO Finland
Intravenous
2.2
50.2
577
2821
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
10.2
49.1
99
99
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
8.1
48.8
112
140
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
4.0
48.3
202
519
GX1K5
NOMESCO Finland
Diffusion capacity
33.5
48.2
63
19
R28
ICPC
Limited function/disability (R)
5.6
47.8
143
259
R81
ICPC
Pneumonia
3.2
47.0
256
816
Z2221
NOMESCO Finland
Medical doctor
1.6
46.4
1385
9398
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
17.0
46.3
74
44
N02AX02
ATC
tramadol; systemic, rectal
1.5
46.3
2190
16664
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
46.1
745
4169
ZX108
NOMESCO Finland
Inhalation
8.6
45.7
101
119
R99
ICPC
Respiratory disease other
4.9
45.6
155
325
A02BC01
ATC
omeprazole; systemic
1.6
44.7
1510
10563
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
44.7
1557
10978
Z3231
NOMESCO Finland
Registered nurse
1.6
44.6
1457
10108
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
44.5
404
1761
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.4
43.9
226
690
J84
ICD-10 Finland
Other interstitial pulmonary diseases
431.1
43.2
43
*
R03BA01
ATC
beclometasone; inhalant
1.9
43.1
726
4118
WX721
NOMESCO Finland
Oxygen concentrator therapy
27.1
42.9
59
22
I50.0
ICD-10 Finland
Congestive heart failure
2.0
42.6
561
2895
C07AB07
ATC
bisoprolol; oral
1.5
41.4
2696
21803
D86.0
ICD-10 Finland
Sarcoidosis of lung
6.2
40.8
113
186
A02BC05
ATC
esomeprazole; systemic
1.5
40.6
1940
14659
R03BA02
ATC
budesonide; inhalant
1.8
40.0
850
5194
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.8
39.6
172
458
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
39.6
694
3982
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
39.2
969
6196
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.6
38.8
138
304
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.0
38.5
162
419
R03BA05
ATC
fluticasone; inhalant
1.7
38.5
839
5165
GDA10
NOMESCO Finland
Biopsy of lung
21.8
38.3
56
26
GX1D5
NOMESCO Finland
Flow volume spirometry
72.4
37.9
43
6
J01FA10
ATC
azithromycin; systemic
1.5
37.2
2304
18279
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
36.8
2120
16564
R03DC03
ATC
montelukast; oral
1.8
36.4
671
3908
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
36.4
557
3037
WZC30
NOMESCO Finland
Teaching
1.8
36.4
686
4025
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
36.2
352
1585
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.1
36.0
419
2048
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
68.7
36.0
41
6
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
35.9
1493
10859
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.7
35.2
255
980
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
35.2
549
3015
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
34.9
177
535
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
25.5
34.4
48
19
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
8.5
34.2
76
91
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
34.0
626
3640
A07AA02
ATC
nystatin; oral
2.1
33.9
392
1906
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
33.9
600
3441
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
33.8
514
2795
L88
ICPC
Rheumatoid/seropositive arthritis
2.8
33.3
227
841
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
74.6
32.8
37
5
M34.1
ICD-10 Finland
CR(E)ST syndrome
13.8
32.5
56
41
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
15.9
32.0
52
33
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
32.0
959
6419
L04AA01
ATC
[U] ciclosporin; systemic
4.5
31.9
115
258
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.2
31.7
123
297
J43.8
ICD-10 Finland
Other emphysema
12.8
31.5
56
44
G47.3
ICD-10 Finland
Sleep apnoea
1.6
31.5
974
6568
E0000UV
ATC
NA
1.4
31.3
1754
13498
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.1
31.2
101
202
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
31.0
367
1803
D07AC01
ATC
betamethasone; topical
1.5
30.7
1605
12168
JN4BD
NOMESCO Finland
Extensive body CT
1.8
30.7
634
3816
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
30.7
391
1982
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
7.5
30.7
73
98
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.7
30.7
89
157
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
30.6
530
3010
J01FF01
ATC
clindamycin; systemic
1.5
30.6
1254
9028
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
30.5
1773
13722
M05BA07
ATC
risedronic acid; oral
2.7
30.5
214
806
F1246
NOMESCO Finland
NA
18.2
30.4
47
26
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.8
30.4
131
348
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.7
30.3
66
77
XW000
NOMESCO Finland
Bone marrow biopsy
2.4
30.2
268
1150
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.7
30.0
137
382
Z2446
NOMESCO Finland
Social worker
2.2
30.0
325
1537
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
29.7
259
1102
J94.1
ICD-10 Finland
Fibrothorax
37.2
29.3
37
10
A03
ICPC
Fever
1.8
29.2
574
3399
M04AA01
ATC
allopurinol; systemic
1.6
29.2
810
5300
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.1
29.1
166
547
XJC10
NOMESCO Finland
Oesophageal pH monitoring
9.6
28.8
59
62
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
28.7
374
1913
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
28.5
254
1092
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
28.2
275
1238
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.0
28.2
117
301
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
28.1
268
1193
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
28.0
338
1674
XX9XE
NOMESCO Finland
Other ultrasound examination
5.8
28.0
80
139
L04AB01
ATC
etanercept; parenteral
5.4
28.0
85
159
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
7.2
27.9
68
95
J20
ICD-10 Finland
Acute bronchitis
1.9
27.8
446
2466
N02BE01
ATC
paracetamol; systemic, rectal
1.5
27.7
4203
38397
R06.2
ICD-10 Finland
Wheezing
2.5
27.4
226
933
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
18.4
27.4
42
23
M01CB01
ATC
sodium aurothiomalate; parenteral
3.9
27.2
115
301
WX872
NOMESCO Finland
Intensive care
2.2
27.2
298
1417
H02AB04
ATC
methylprednisolone; systemic
1.6
27.2
693
4429
R06AE07
ATC
cetirizine; oral
1.4
27.1
1742
13661
N03AX16
ATC
pregabalin; oral
1.5
27.0
1074
7650
J80
ICD-10 Finland
Adult respiratory distress syndrome
9.7
26.6
54
56
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
14.2
26.6
45
32
A02BC03
ATC
lansoprazole; oral
1.4
26.4
1445
10988
J45.8
ICD-10 Finland
Mixed asthma
2.9
26.3
168
598
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
26.3
895
6147
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
26.2
710
4607
J96.0
ICD-10 Finland
Acute respiratory failure
3.8
26.1
114
307
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
21.2
26.0
38
18
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
13.3
25.9
45
34
B01AA03
ATC
warfarin; systemic
1.4
25.2
1286
9626
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
25.2
1839
14699
J01FA15
ATC
telithromycin; oral
1.8
25.2
424
2381
XG460
NOMESCO Finland
Short time oxymetry
3.2
25.2
135
428
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
+∞
25.0
24
*
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.9
25.0
83
172
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
24.8
1259
9409
F2680
NOMESCO Finland
NA
14.1
24.8
42
30
L04AB04
ATC
adalimumab; parenteral
4.3
24.6
93
220
2AX04
NOMESCO Finland
NA
32.2
24.6
32
10
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
7.7
24.4
57
75
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
24.4
418
2361
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
24.4
1918
15503
WX726
NOMESCO Finland
High-flow oxygen therapy
18.6
24.3
37
20
J01DB01
ATC
cefalexin; oral
1.4
24.2
3819
34520
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
23.9
333
1745
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
23.8
1436
11069
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.4
23.4
199
838
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
23.4
179
712
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
23.3
503
3059
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
23.1
1388
10678
WX722
NOMESCO Finland
PEEP
2.1
23.1
276
1361
L01AA01
ATC
cyclophosphamide; systemic
7.2
23.0
56
79
J43.2
ICD-10 Finland
Centrilobular emphysema
9.5
22.9
47
50
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
22.9
685
4547
R03AK11
ATC
formoterol and fluticasone; inhalant
3.1
22.6
129
425
3A006
NOMESCO Finland
NA
230.9
22.6
23
*
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.1
22.6
124
401
RS123
NOMESCO Finland
NA
23.0
22.5
32
14
Z51.5
ICD-10 Finland
Palliative care
1.8
22.4
373
2085
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
6.1
22.3
61
101
J01FA09
ATC
clarithromycin; systemic
1.4
22.2
1237
9374
A01AB09
ATC
miconazole; local oral
1.7
22.0
444
2643
XG405
NOMESCO Finland
Education on PEF monitoring
3.6
21.9
101
286
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
+∞
21.9
21
*
R03AC03
ATC
terbutaline; inhalant
1.6
21.3
589
3826
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.0
21.3
86
218
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
21.2
234
1114
UJF32
NOMESCO Finland
Coloscopy
1.4
21.2
1275
9785
L04AA24
ATC
abatacept; parenteral
10.9
21.1
40
37
AN1
HP
Coronary angiography
1.5
21.1
732
5031
JN4AD
NOMESCO Finland
Body CT examination
1.8
21.0
411
2424
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
20.9
751
5199
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
60.2
20.9
24
*
J99.0
ICD-10 Finland
Rheumatoid lung disease
60.2
20.9
24
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
20.8
450
2732
120
Kela drug reimbursment
Hypogammaglobulinaemia
19.5
20.8
31
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
20.7
1682
13574
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.2
20.6
109
344
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
9.8
20.5
41
42
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
5.9
20.5
57
97
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.1
20.4
240
1176
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
20.4
295
1568
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
20.3
295
1572
M34.0
ICD-10 Finland
Progressive systemic sclerosis
22.4
20.3
29
13
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
20.3
276
1432
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
20.3
1536
12241
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
8.8
20.3
43
49
C01DA14
ATC
isosorbide mononitrate; oral
1.4
20.1
1017
7551
WX110
NOMESCO Finland
Local anesthesy
1.3
20.1
2888
25313
R03DA04
ATC
theophylline; systemic, rectal
1.9
20.0
321
1775
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
20.8
19.9
29
14
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.9
19.8
302
1638
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
19.8
284
1506
SPAT1262
SPAT
Handing over of treatment supplies
1.4
19.7
938
6882
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.7
19.7
87
239
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
19.6
522
3357
J05AB11
ATC
valaciclovir; oral
1.6
19.5
548
3575
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
19.4
684
4714
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.0
19.3
111
370
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
19.3
1206
9294
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.9
19.2
116
400
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.6
19.2
145
572
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
19.1
209
992
5AB14
NOMESCO Finland
NA
14.0
19.0
32
23
C03DA01
ATC
spironolactone; oral
1.6
19.0
576
3831
R03BB01
ATC
ipratropium bromide; inhalant
2.0
19.0
259
1347
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.7
19.0
129
480
Z57.2
ICD-10 Finland
Occupational exposure to dust
6.5
18.9
49
76
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
12.8
18.8
33
26
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
18.8
18
*
J12.8
ICD-10 Finland
Other viral pneumonia
5.0
18.7
60
121
WX002
NOMESCO Finland
Sedation and analgesia
1.4
18.7
931
6881
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
18.7
204
969
ZXA10
NOMESCO Finland
Bilateral
1.4
18.5
900
6620
N02AA05
ATC
oxycodone; systemic
1.5
18.5
789
5657
J01DA01
ATC
[U] cefalexin; systemic
1.3
18.4
2835
24936
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.1
18.3
71
174
M10.9
ICD-10 Finland
Gout, unspecified
1.7
18.3
374
2231
XF402
NOMESCO Finland
ECG with work load test
1.6
18.3
564
3763
RK320
NOMESCO Finland
NA
4.0
18.2
73
185
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.6
18.1
136
538
GAA31
NOMESCO Finland
Thoracoscopy
6.6
18.1
46
70
M35.1
ICD-10 Finland
Other overlap syndromes
7.0
18.0
44
63
E000001
ATC
NA
1.4
17.9
844
6168
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
17.9
415
2571
J67.0
ICD-10 Finland
Farmer lung
13.0
17.9
31
24
M33.2
ICD-10 Finland
Polymyositis
10.1
17.8
35
35
SPAT1325
SPAT
Vaccination
1.3
17.7
1751
14464
XPX04
NOMESCO Finland
Angioscopy
9.8
17.6
35
36
I73.0
ICD-10 Finland
Raynaud syndrome
3.8
17.5
75
201
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
17.5
727
5178
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
17.5
268
1456
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
15.6
17.4
28
18
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
17.4
381
2319
R03AC12
ATC
salmeterol; inhalant
1.9
17.4
247
1307
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
17.4
1172
9126
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
17.0
17.4
27
16
ZXA00
NOMESCO Finland
Right side
1.3
17.3
1310
10391
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.5
17.3
61
137
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
17.2
1281
10131
M25.5
ICD-10 Finland
Pain in joint
1.4
17.1
1052
8061
SPAT1263
SPAT
Sampling
1.3
17.1
1908
16010
GX2C5
NOMESCO Finland
Short-lasting oximetry
16.0
17.0
27
17
M05BX04
ATC
denosumab; parenteral
1.9
16.9
253
1364
R01AD09
ATC
mometasone; nasal
1.3
16.9
1660
13678
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
16.8
493
3246
R29
ICPC
Respiratory symptom/complaint other
1.9
16.8
256
1388
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
16.8
393
2441
J46
ICD-10 Finland
Status asthmaticus
2.4
16.8
138
574
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
16.7
357
2160
R01AD12
ATC
fluticasone furoate; nasal
1.4
16.6
966
7328
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
16.6
1268
10059
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.5
16.6
131
534
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.2
16.5
63
153
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
16.5
1371
11018
D07AC13
ATC
mometasone; topical
1.3
16.5
1234
9758
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
4.0
16.4
65
163
ZXD05
NOMESCO Finland
Urgent procedure
1.3
16.4
1410
11382
C09AA05
ATC
ramipril; oral
1.3
16.4
1355
10870
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
5.4
16.4
49
92
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
16.4
245
1321
B02.9
ICD-10 Finland
Zoster without complication
1.8
16.4
283
1606
1CX01
NOMESCO Finland
NA
14.3
16.3
27
19
XQ800
NOMESCO Finland
Prick test
1.9
16.2
242
1305
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.4
16.2
42
66
1240
FHL
Bronchoscopy
3.3
16.2
83
258
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.0
16.1
93
314
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.5
16.0
512
3440
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.0
16.0
63
158
5BA08
NOMESCO Finland
NA
5.3
15.8
48
92
N02AA01
ATC
morphine; systemic, rectal
2.9
15.7
94
325
M05.1
ICD-10 Finland
Rheumatoid lung disease
60.2
15.7
18
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
15.7
1893
15996
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
15.6
15
*
A28
ICPC
Limited function/disability NOS
1.4
15.6
828
6170
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
15.5
100
361
R03AC13
ATC
formoterol; inhalant
1.9
15.5
236
1280
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.4
15.5
55
125
N03AX12
ATC
gabapentin; oral
1.5
15.5
642
4568
RK110
NOMESCO Finland
NA
3.9
15.2
63
165
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.1
15.2
163
771
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.8
15.2
50
105
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
15.1
365
2284
M33.1
ICD-10 Finland
Other dermatomyositis
13.1
15.1
26
20
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
13.1
15.1
26
20
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
5.2
15.1
46
89
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.0
14.9
59
149
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.6
14.8
111
438
D07AB08
ATC
desonide; topical
1.6
14.8
439
2900
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
14.7
142
642
A46
ICD-10 Finland
Erysipelas
1.4
14.7
675
4898
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
14.6
630
4509
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
21.1
14.6
21
10
M79.6
ICD-10 Finland
Pain in limb
1.3
14.6
1458
11983
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
14.6
14
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
14.4
114
466
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
14.4
322
1974
J96.9
ICD-10 Finland
Respiratory failure, unspecified
4.4
14.4
51
116
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
15.4
14.4
23
15
R01AD08
ATC
fluticasone; nasal
1.3
14.3
1031
8078
1XC02
NOMESCO Finland
NA
4.2
14.3
53
126
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.8
14.3
47
99
4040
NOMESCO Finland
NA
27.2
14.3
19
7
I27.0
ICD-10 Finland
Primary pulmonary hypertension
10.4
14.2
27
26
291
Kela drug reimbursment
Tofacitinib
13.4
14.2
24
18
N05CF01
ATC
zopiclone; oral
1.3
14.1
1549
12891
WX882
NOMESCO Finland
High dependency care
2.2
14.1
145
676
B01AB05
ATC
enoxaparin; parenteral
1.3
14.0
1398
11478
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
14.0
1431
11787
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
14.0
323
1999
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
13.9
345
2177
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.6
13.9
61
169
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
7.5
13.9
32
43
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
13.8
372
2396
81
HP
Angiography of the heart and coronary arteries
1.6
13.8
410
2705
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
13.8
1032
8129
J02AC01
ATC
fluconazole; systemic
1.3
13.7
1346
11018
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
13.7
256
1489
TGD00
NOMESCO Finland
Needle biopsy of lung
5.0
13.6
43
87
GX2D5
NOMESCO Finland
Sleep oximetry
7.6
13.6
31
41
AK3
HP
BLTX (both lung transplants)
75.3
13.6
15
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
13.5
297
1813
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.8
13.5
225
1263
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
140.3
13.4
14
*
H02AB09
ATC
hydrocortisone; systemic
2.5
13.4
100
397
R4190
NOMESCO Finland
Nutritional therapy
2.2
13.4
137
635
J01GB01
ATC
tobramycin; inhalant, parenteral
25.8
13.3
18
7
J45
ICD-10 Finland
Asthma
1.6
13.3
362
2335
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.2
13.3
134
617
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
21.2
13.3
19
9
ZY010
NOMESCO Finland
Hospital outpatient
2.1
13.3
149
720
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
13.2
368
2392
R4120
NOMESCO Finland
Occupational therapy
1.7
13.1
264
1569
M31.3
ICD-10 Finland
Wegener granulomatosis
6.1
13.1
35
58
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.4
13.1
62
183
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.1
13.0
72
238
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.8
13.0
239
1383
J98.4
ICD-10 Finland
Other disorders of lung
8.3
13.0
28
34
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
13.0
197
1070
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
12.9
461
3173
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
12.9
144
696
J42
ICD-10 Finland
Unspecified chronic bronchitis
3.0
12.9
75
256
A02BA02
ATC
ranitidine; systemic
1.3
12.9
941
7376
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
12.9
115
501
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
12.8
845
6517
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.2
12.7
123
558
M05BA06
ATC
ibandronic acid; systemic
2.5
12.7
95
377
L01CB
ATC
Podophyllotoxin derivatives
9.7
12.7
25
26
318
Kela drug reimbursment
Teriparatide
4.8
12.6
41
86
J93.8
ICD-10 Finland
Other pneumothorax
4.6
12.5
42
91
304
Kela drug reimbursment
Dornase alfa
+∞
12.5
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
12.5
12
*
R74
ICPC
Upper respiratory infection acute
1.4
12.5
805
6186
D07XC01
ATC
betamethasone, combinations; topical
1.4
12.5
534
3817
L04AC07
ATC
tocilizumab; parenteral
10.0
12.4
24
24
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
12.4
226
1302
Z94.3
ICD-10 Finland
Heart and lungs transplant status
130.3
12.4
13
*
ZXA05
NOMESCO Finland
Left side
1.3
12.4
1201
9795
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
12.4
353
2306
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
12.3
214
1220
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.1
12.3
66
215
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
12.2
536
3845
J05AB01
ATC
aciclovir; systemic
1.4
12.2
807
6223
R05FB02
ATC
cough suppressants and expectorants
1.3
12.2
1713
14625
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.0
12.1
68
228
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.0
12.1
162
842
SPAT1255
SPAT
Intravenous administration of medicine
1.6
12.0
312
1993
R2110
NOMESCO Finland
Giving the first information
1.7
12.0
245
1466
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
21.3
12.0
17
8
J02AC03
ATC
voriconazole; systemic
8.7
12.0
25
29
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
10.0
12.0
23
23
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
9.3
12.0
24
26
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
11.9
529
3808
J01FA01
ATC
erythromycin; systemic
1.5
11.9
437
3026
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
11.9
168
889
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
11.8
193
1078
132
Kela drug reimbursment
Sarcoidosis
4.3
11.7
42
98
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
11.6
168
897
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
11.6
1377
11506
R24
ICPC
Haemoptysis
4.2
11.6
43
104
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.6
11.5
51
144
RS230
NOMESCO Finland
NA
5.1
11.5
35
69
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
13.6
11.4
19
14
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
120.2
11.4
12
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
11.4
1377
11530
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
11.4
1355
11328
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.9
11.3
45
116
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
11.3
1907
16593
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
11.3
359
2411
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.0
11.3
62
206
M54.5
ICD-10 Finland
Low back pain
1.3
11.2
1244
10305
ED1AA
NOMESCO Finland
Mandipular X-ray examination
4.5
11.2
38
84
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
11.2
280
1772
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
11.2
608
4534
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.7
11.2
76
288
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
11.2
184
1030
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
17.0
11.2
17
10
E000003
ATC
NA
1.9
11.2
174
954
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
11.1
69
245
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.9
11.1
35
72
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.4
11.0
39
90
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
5.6
11.0
31
56
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
10.9
91
385
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.4
10.9
90
377
R03BB07
ATC
umeclidinium bromide; inhalant
3.6
10.9
48
135
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.8
10.9
44
115
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.1
10.9
41
101
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
5.9
10.8
29
49
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.2
10.8
104
471
I50.1
ICD-10 Finland
Left ventricular failure
1.6
10.8
268
1691
L04AB05
ATC
certolizumab pegol; parenteral
8.2
10.8
23
28
NG1DA
NOMESCO Finland
X-ray of knees
2.4
10.8
86
355
H05AA02
ATC
teriparatide; parenteral
4.6
10.7
36
79
SPAT1260
SPAT
Consultation of another employee
1.3
10.7
763
5942
L04AA29
ATC
tofacitinib; oral
9.6
10.7
21
22
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
10.7
278
1778
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
4.1
10.7
40
98
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
10.7
1676
14443
C10AA03
ATC
pravastatin; oral
1.5
10.6
373
2561
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.4
10.6
88
371
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
10.5
328
2189
WX740
NOMESCO Finland
Nitrogen oxide therapy
8.5
10.5
22
26
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.6
10.5
74
285
L03
ICPC
Low back symptom/complaint
1.3
10.5
899
7192
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
10.5
364
2490
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.2
10.4
53
167
S97
ICPC
Chronic ulcer skin
1.6
10.4
269
1718
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
10.4
1047
8551
L04AB06
ATC
golimumab; parenteral
5.0
10.4
32
64
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.0
10.4
58
195
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
110.2
10.4
11
*
51701
ICD-8 Finland
Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)
+∞
10.4
10
*
S18
ICPC
Laceration/cut
1.2
10.3
1897
16611
R04.0
ICD-10 Finland
Epistaxis
1.5
10.3
349
2376
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
10.3
187
1080
A02BA03
ATC
famotidine; systemic
1.7
10.3
201
1187
WX720
NOMESCO Finland
Own respiration
1.8
10.3
161
887
A01AB04
ATC
amphotericin B; local oral
1.7
10.3
225
1377
XF404
NOMESCO Finland
Ambulatory ECG
1.4
10.2
429
3052
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
18.8
10.2
15
8
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
7.1
10.2
24
34
J37.0
ICD-10 Finland
Chronic laryngitis
2.0
10.1
128
654
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
6.9
10.1
24
35
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.3
10.1
93
414
N07BA03
ATC
varenicline; oral
1.9
10.0
153
834
B01AC04
ATC
clopidogrel; oral
1.3
10.0
856
6841
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
10.0
1162
9660
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
10.0
115
565
RS220
NOMESCO Finland
NA
2.9
10.0
58
200
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
40.1
10.0
12
*
J01XB01
ATC
colistin; inhalant, parenteral
40.1
10.0
12
*
6BA02
NOMESCO Finland
NA
7.2
10.0
23
32
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
10.0
175
1002
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
9.9
853
6820
H26.3
ICD-10 Finland
Drug-induced cataract
4.2
9.9
36
86
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.9
605
4600
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
9.9
236
1478
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.5
9.9
44
126
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
9.8
256
1640
E000002
ATC
NA
1.5
9.8
394
2781
D07AA02
ATC
hydrocortisone; topical
1.4
9.8
477
3491
L04AA17
ATC
[U] adalimumab; parenteral
5.4
9.8
28
52
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.0
9.8
127
657
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
8.7
9.8
20
23
Z71.8
ICD-10 Finland
Other specified counselling
1.3
9.7
846
6775
B59
ICD-10 Finland
Pneumocystosis
13.4
9.7
16
12
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.8
9.6
158
887
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
9.6
702
5485
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
9.6
269
1756
L95
ICPC
Osteoporosis
1.9
9.6
130
684
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
9.6
151
834
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
9.6
321
2182
H03AA01
ATC
levothyroxine sodium; systemic
1.3
9.5
895
7241
293
Kela drug reimbursment
Baricitinib
11.4
9.5
17
15
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
6.3
9.5
24
38
5823
FHL
Lung avobiopsy and wedge resection
15.0
9.5
15
10
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
100.2
9.4
10
*
C08CA05
ATC
nifedipine; systemic
1.5
9.4
331
2275
C02KX04
ATC
macitentan; oral
17.5
9.4
14
8
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
9.4
9
*
P01AB01
ATC
metronidazole; oral, rectal
1.2
9.4
1496
12876
R63.4
ICD-10 Finland
Abnormal weight loss
1.8
9.4
155
872
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.5
9.3
41
117
A04
ICPC
Weakness/tiredness general
1.4
9.2
528
3970
NDG30
NOMESCO Finland
Fusion of wrist, total
4.1
9.2
34
83
WX402
NOMESCO Finland
General anaesthesia
1.3
9.2
598
4589
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.5
9.2
71
292
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.4
9.2
74
311
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
9.2
126
2116
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.5
9.1
69
277
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
9.1
134
724
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
9.1
286
1918
WVA20
NOMESCO Finland
Medicine administration
2.1
9.1
94
442
R60.0
ICD-10 Finland
Localized oedema
1.4
9.1
493
3679
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
9.1
366
2585
J94.8
ICD-10 Finland
Other specified pleural conditions
2.1
9.0
96
456
ZX121
NOMESCO Finland
Central venous catheter
5.6
9.0
25
45
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
36.7
9.0
11
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
10.0
9.0
17
17
3006
Kela drug reimbursment
Baricitinib
10.0
9.0
17
17
K29.7
ICD-10 Finland
Gastritis, unspecified
1.8
9.0
148
831
R03AC19
ATC
olodaterol; inhalant
3.8
9.0
36
95
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
8.9
325
2249
C02KX01
ATC
bosentan; oral
18.6
8.9
13
7
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
8.9
411
2979
M01CB03
ATC
auranofin; oral
3.0
8.9
49
165
M06
ICD-10 Finland
Other rheumatoid arthritis
3.6
8.9
38
106
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.8
8.9
36
96
-1
NOMESCO Finland
NA
1.2
8.9
1120
9387
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
5.7
8.9
24
42
R95
ICPC
Chron obstructive pulmonary disease
1.8
8.8
139
771
N06AX11
ATC
mirtazapine; oral
1.2
8.8
1251
10623
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
8.8
83
1539
RK250
NOMESCO Finland
NA
3.8
8.8
35
92
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
3.8
8.8
35
92
RK310
NOMESCO Finland
NA
10.7
8.8
16
15
ZX197
NOMESCO Finland
NA
10.7
8.8
16
15
M10
ICD-10 Finland
Gout
1.6
8.8
205
1280
R03BB05
ATC
aclidinium bromide; inhalant
5.1
8.7
26
51
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.4
8.7
40
118
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.9
8.7
121
643
3AC01
NOMESCO Finland
NA
2.9
8.7
51
178
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.5
8.7
308
2120
TK800
NOMESCO Finland
Hemodialysis
2.0
8.7
103
514
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
50.1
8.7
10
*
XA421
NOMESCO Finland
Nocturnal polygraphy
5.0
8.6
26
52
R53
ICD-10 Finland
Malaise and fatigue
1.3
8.6
852
6934
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
5.5
8.6
24
44
D11
ICPC
Diarrhoea
1.5
8.5
324
2264
J98.2
ICD-10 Finland
Interstitial emphysema
10.0
8.5
16
16
Z31.5
ICD-10 Finland
Genetic counselling
1.9
8.5
125
678
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
8.5
474
3551
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
27.5
8.5
11
*
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
27.5
8.5
11
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.2
8.5
80
363
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
4.2
8.5
30
71
B01AB04
ATC
dalteparin; parenteral
1.6
8.4
216
1380
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
8.4
495
3739
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
8.4
253
1680
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.5
8.4
275
1858
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
8.4
168
1004
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
8.4
63
256
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.7
8.4
35
96
ZX100
NOMESCO Finland
Oral
2.3
8.4
72
314
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.0
8.3
105
538
5168X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies
+∞
8.3
8
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
8.3
184
1134
XX7LW
NOMESCO Finland
NA
6.2
8.3
21
34
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.7
8.3
170
1023
D72.1
ICD-10 Finland
Eosinophilia
4.6
8.3
27
59
L04AA37
ATC
baricitinib; oral
9.4
8.3
16
17
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
8.3
158
933
D07AD01
ATC
clobetasol; topical
1.3
8.2
582
4523
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.4
8.2
67
283
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
8.2
196
1228
ZX114
NOMESCO Finland
Intramuscular
2.4
8.2
65
272
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.9
8.2
108
562
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
8.2
1623
14235
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
8.2
363
2614
D02AE01
ATC
carbamide; topical
1.5
8.2
259
1741
L04AA11
ATC
[U] etanercept; parenteral
4.9
8.2
25
51
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
8.2
444
3310
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.4
8.2
66
276
N06AA09
ATC
amitriptyline; systemic
1.4
8.2
403
2958
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
8.1
139
794
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
5.4
8.1
23
43
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.0
8.1
43
142
M01AB55
ATC
diclofenac, combinations; oral
1.5
8.1
306
2137
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.9
8.1
107
558
ZX140
NOMESCO Finland
Intra articular
3.2
8.1
40
126
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.6
8.1
217
1406
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
17.2
8.1
12
7
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
8.0
354
2547
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.5
8.0
35
100
XG430
NOMESCO Finland
Spiroegometry
22.0
8.0
11
5
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
22.0
8.0
11
5
AA1AD
NOMESCO Finland
CT of head and brain
1.2
8.0
1124
9516
A91
ICPC
Abnormal result investigation NOS
1.7
8.0
174
1064
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.0
8.0
98
498
I50
ICD-10 Finland
Heart failure
1.7
8.0
169
1028
M01AH02
ATC
rofecoxib; oral
1.3
8.0
574
4475
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
8.0
177
1088
M48.0
ICD-10 Finland
Spinal stenosis
1.3
8.0
570
4435
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.2
8.0
79
367
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
4.4
7.9
27
62
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
7.9
427
3183
A02BA04
ATC
nizatidine; systemic
1.4
7.9
356
2572
RS221
NOMESCO Finland
NA
2.4
7.9
65
278
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
7.7
7.9
17
22
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.5
7.9
261
1772
UDC00
NOMESCO Finland
Ear microscopy
1.5
7.9
293
2041
L57.0
ICD-10 Finland
Actinic keratosis
1.3
7.9
486
3702
C01AA05
ATC
digoxin; systemic
1.4
7.8
459
3467
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.2
7.8
76
351
S22.2
ICD-10 Finland
Fracture of sternum
3.7
7.8
32
87
SBA00
NOMESCO Finland
Microbiological examinations
2.0
7.8
94
474
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
7.8
380
2783
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.4
7.8
35
103
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
7.8
1315
11348
SBA10
NOMESCO Finland
Measurement of excretion of saliva
2.8
7.7
46
164
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.4
7.7
26
59
C08CA02
ATC
felodipine; oral
1.3
7.7
467
3544
K07
ICPC
Swollen ankles/oedema
1.6
7.7
197
1257
4038
NOMESCO Finland
NA
45.0
7.7
9
*
FXE00
NOMESCO Finland
Use of ECLA
15.0
7.7
12
8
UGC02
NOMESCO Finland
Rigid bronchoscopy
5.0
7.7
23
46
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
7.7
428
3207
XX4AW
NOMESCO Finland
NA
7.4
7.7
17
23
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
5.5
7.7
21
38
WX730
NOMESCO Finland
Conventional respirator
2.1
7.7
77
361
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.2
7.6
37
115
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.6
7.6
32
89
L17
ICPC
Foot/toe symptom/complaint
1.2
7.6
1005
8450
WW500
NOMESCO Finland
Blood transfusion
1.6
7.6
172
1067
M02AA07
ATC
piroxicam; topical
1.2
7.6
1611
14197
R06AX27
ATC
desloratadine; oral
1.3
7.6
792
6481
SPAT1059
SPAT
Spirometry at the office
1.5
7.6
216
1418
3005
Kela drug reimbursment
Tofacitinib
8.0
7.6
16
20
207
Kela drug reimbursment
Chronic arrhythmias
1.3
7.5
764
6231
J92
ICD-10 Finland
Pleural plaque
8.8
7.5
15
17
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
7.5
325
2329
M60.9
ICD-10 Finland
Myositis, unspecified
3.9
7.5
29
75
DHA10
NOMESCO Finland
Biopsy of cavity of nose
3.1
7.5
38
122
R06AX22
ATC
ebastine; oral
1.3
7.5
527
4094
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
7.5
345
4589
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.6
7.5
167
1031
XX1VW
NOMESCO Finland
Written report from radiologist
3.2
7.5
36
112
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.4
1008
8494
3A064
NOMESCO Finland
NA
4.0
7.4
28
71
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.5
7.4
55
221
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
7.4
1632
14423
N06DA02
ATC
donepezil; oral
0.6
7.4
129
2048
S22.3
ICD-10 Finland
Fracture of rib
1.5
7.4
274
1906
R96
ICPC
Asthma
1.4
7.4
323
2321
TNG10
NOMESCO Finland
Puncture of knee
2.6
7.4
52
205
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
7.6
7.4
16
21
R03BB06
ATC
glycopyrronium bromide; inhalant
3.4
7.4
33
97
NDG74
NOMESCO Finland
Fusion of first IP joint
5.3
7.4
21
40
49099
ICD-8 Finland
Bronchitis, unspecified
2.8
7.4
45
164
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
3.5
7.3
32
92
N06AX16
ATC
venlafaxine; oral
1.4
7.3
387
2873
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
3.1
7.3
38
125
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
7.3
7
*
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
9.4
7.3
14
15
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
7.3
90
459
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
5.4
7.2
20
37
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.3
7.2
63
277
S20.2
ICD-10 Finland
Contusion of thorax
1.6
7.2
174
1099
R13
ICD-10 Finland
Dysphagia
1.5
7.2
270
1887
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
7.2
166
1038
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.2
1645
14584
UJD02
NOMESCO Finland
Gastroscopy
1.5
7.1
208
1373
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.1
2774
25685
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
20.0
7.1
10
5
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
4.8
7.1
22
46
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
4.4
7.1
24
55
A06AD11
ATC
lactulose; oral
1.3
7.1
708
5760
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.1
1028
8720
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.2
7.1
68
313
B37.0
ICD-10 Finland
Candidal stomatitis
2.7
7.1
46
173
F03
ICD-10 Finland
Unspecified dementia
0.6
7.1
88
1513
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.3
7.1
59
253
L01BB01
ATC
NA
5.6
7.0
19
34
J43.1
ICD-10 Finland
Panlobular emphysema
8.8
7.0
14
16
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.2
7.0
67
307
K76.9
ICD-10 Finland
Liver disease, unspecified
2.4
7.0
56
236
R03AC18
ATC
indacaterol; inhalant
2.7
7.0
45
167
J01DA08
ATC
[U] cefaclor; oral
1.4
7.0
286
2031
J01DA06
ATC
[U] cefuroxime; systemic
1.3
7.0
543
4279
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
7.0
328
4351
UDM02
NOMESCO Finland
Sinoscopy
2.0
7.0
79
391
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
4.4
6.9
23
52
M01CC01
ATC
penicillamine; oral
6.3
6.9
17
27
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
6.9
643
5184
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.0
6.9
79
393
B01AF02
ATC
apixaban; oral
1.3
6.9
473
3657
L28
ICPC
Limited function/disability (L)
1.3
6.9
725
5937
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
6.9
141
851
J86.9
ICD-10 Finland
Pyothorax without fistula
2.5
6.8
49
196
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.7
6.8
129
762
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.4
6.8
295
2116
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
6.8
918
7724
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.7
6.8
139
839
I20.0
ICD-10 Finland
Unstable angina
2.6
6.8
48
189
F2682
NOMESCO Finland
NA
6.7
6.8
16
24
XJC00
NOMESCO Finland
Oesophageal manometry
4.2
6.8
24
58
R04
ICPC
Breathing problem other
1.7
6.8
123
718
11
HP
Coronary artery bypass surgery
1.7
6.8
140
848
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
3.7
6.7
27
73
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
16.7
6.7
10
6
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
6.7
322
2352
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.5
6.7
197
1307
XF622
NOMESCO Finland
Measurement of minute volume of heart
3.8
6.6
26
69
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
6.6
193
1275
R01AD01
ATC
beclometasone; nasal
1.3
6.6
517
4076
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
6.6
64
295
WNF00
NOMESCO Finland
Infection source and contact determination
3.4
6.6
29
85
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.4
6.6
29
85
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
12.2
6.6
11
9
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.8
6.6
39
140
-44
ICPC
Preventive immunization/medic
1.4
6.6
369
2772
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.6
107
606
B01AB10
ATC
tinzaparin; parenteral
1.4
6.6
272
1938
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.6
6.5
175
1134
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.5
1712
15322
S29
ICPC
Skin symptom/complaint other
1.3
6.5
672
5491
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.3
6.5
53
227
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
6.5
22
579
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
5.0
6.5
19
38
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
6.4
255
1801
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.0
6.4
75
375
I26
ICD-10 Finland
Pulmonary embolism
2.7
6.4
42
159
UGC08
NOMESCO Finland
Rigid bronchoscopy with biopsy of lung
69.9
6.4
7
*
I20.09
ICD-10 Finland
Unstable angina
1.4
6.4
285
2055
J32.4
ICD-10 Finland
Chronic pansinusitis
2.4
6.4
52
221
S20
ICPC
Corn/callosity
1.9
6.4
86
456
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.3
6.4
29
87
N06DA03
ATC
rivastigmine; oral, transdermal
0.6
6.4
70
1241
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
7.4
6.4
14
19
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.4
2004
18185
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.8
6.4
105
595
C10AX09
ATC
ezetimibe; oral
1.3
6.4
454
3533
R78
ICPC
Acute bronchitis/bronchiolitis
1.9
6.4
83
433
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.4
2308
21177
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.1
6.4
65
308
T90
ICPC
Diabetes non-insulin dependent
1.2
6.4
1053
9047
A01
ICPC
Pain general/multiple sites
1.4
6.3
284
2049
D06BB04
ATC
podophyllotoxin; topical
1.8
6.3
103
583
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
6.3
108
619
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.9
6.3
89
479
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
6.3
428
3309
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
8.1
6.3
13
16
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
8.1
6.3
13
16
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
8.1
6.3
13
16
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.3
576
4631
L03AA02
ATC
filgrastim; parenteral
1.8
6.3
106
604
B07.9
ICD-10 Finland
Verruca simplex
1.8
6.3
104
590
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
11.0
6.3
11
10
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.5
6.3
186
1235
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
9.2
6.3
12
13
602
Kela drug reimbursment
Children's severe malnutrition
9.2
6.3
12
13
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.3
2630
24387
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.9
6.3
83
439
R06AE09
ATC
levocetirizine; oral
1.3
6.3
427
3304
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
4.0
6.3
23
58
M03BX02
ATC
tizanidine; oral
1.2
6.3
2302
21136
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
18.0
6.3
9
5
N30.2
ICD-10 Finland
Other chronic cystitis
2.7
6.2
39
146
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.3
6.2
54
239
R76.0
ICD-10 Finland
Raised antibody titre
4.8
6.2
19
40
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.2
114
668
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
6.2
451
3520
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.5
6.2
225
1564
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.2
6.2
30
95
R07.3
ICD-10 Finland
Other chest pain
1.3
6.2
355
2676
NXL00
NOMESCO Finland
Biopsy of muscle
4.1
6.2
22
54
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.5
6.2
44
175
J93.9
ICD-10 Finland
Pneumothorax, unspecified
3.1
6.2
31
101
HA1AA
NOMESCO Finland
X-ray mammography
1.5
6.2
227
1580
C09CA01
ATC
losartan; oral
1.2
6.2
1057
9107
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.8
6.1
97
541
WX723
NOMESCO Finland
CPAP therapy
1.7
6.1
114
673
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1.9
6.1
85
454
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
6.1
150
953
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.1
6.1
66
322
R05CB01
ATC
acetylcysteine; inhalant, oral
1.9
6.1
79
413
J98.6
ICD-10 Finland
Disorders of diaphragm
3.4
6.1
27
80
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
4.6
6.1
19
41
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
6.1
871
7373
C10AA05
ATC
atorvastatin; oral
1.2
6.1
1855
16781
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.0
1628
14579
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
1.9
6.0
83
445
J94.9
ICD-10 Finland
Pleural condition, unspecified
2.9
6.0
33
114
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.7
6.0
37
137
M01AH05
ATC
etoricoxib; oral
1.2
6.0
2221
20373
M32
ICD-10 Finland
Systemic lupus erythematosus
10.0
6.0
11
11
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
6.7
6.0
14
21
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
6.0
72
366
N06DX01
ATC
memantine; oral
0.7
6.0
166
2399
R01
ICPC
Pain respiratory system
2.3
6.0
52
228
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1668
6451
3.21
321.01
9.1
6.8
kpa
5.0
5.1
0.80
1603
6120
(3027801) Oxygen [Partial pressure] in Arterial blood
1666
6449
3.20
320.02
9.1
6.8
kpa
10.2
12.1
59.14
1604
6114
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
787
1835
4.79
315.38
1.8
1.8
u/l
38.4
38.3
0.07
716
1562
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
615
1158
5.81
314.73
1.8
1.4
g/l
0.2
0.2
2.91
590
1091
(3003396) Base excess in Arterial blood by calculation
1651
6431
3.17
312.92
9.2
6.8
mmol/l
1.4
1.1
2.72
1370
4942
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
616
716
9.49
307.65
1.8
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4099
22534
3.66
307.65
12.7
5.9
%
24.5
26.3
21.10
4006
20703
(3028026) IgM [Mass/volume] in Serum or Plasma
1014
2588
4.52
307.65
2.2
1.9
g/l
1.1
1.4
3.31
941
2301
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1990
6703
3.96
307.65
1.4
1.3
iu/ml
57.3
36.6
4.31
698
2028
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
443
167
28.59
307.65
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
4323
23343
4.15
307.65
11.7
5.4
e9/l
0.7
0.6
21.20
3952
19799
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
552
652
9.23
307.65
1.2
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2177
9143
3.18
307.65
2.8
1.8
—
—
—
0
0
(44790048)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
828
793
11.98
307.65
2.1
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
598
675
9.74
307.65
2.4
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
987
1572
7.33
307.65
1.8
1.5
titre
279.5
230.8
0.25
64
76
(44806118)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(4010399)
1144
3286
4.08
307.65
2.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
2242
5241
6.27
307.65
1.5
1.3
titre
602.8
502.3
1.55
679
1108
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
624
933
7.36
307.65
1.4
1.2
u/ml
7.8
3.2
0.74
92
83
(3042631) Mycobacterium sp identified in Specimen
589
736
8.78
307.65
3.0
2.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
564
858
7.16
307.65
12.4
4.4
iu/ml
1522.1
2324.4
0.15
132
115
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
583
631
10.14
307.65
1.8
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4341
23892
4.06
307.65
11.8
5.5
e9/l
1.9
1.9
0.05
4004
20610
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1724
6284
3.46
307.65
2.6
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
4052
22167
3.62
307.65
12.1
5.7
%
60.5
58.4
23.24
3958
20475
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
749
1141
7.37
307.65
1.9
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1728
6264
3.48
307.65
2.6
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
781
1299
6.77
307.65
1.7
1.4
iu/ml
11.4
17.2
0.56
33
29
(3000492) Spirometry study
1219
3694
3.90
307.65
2.9
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
879
1108
9.14
307.65
2.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
704
860
9.16
307.65
2.4
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
4332
23484
4.14
307.65
11.7
5.4
e9/l
0.0
0.0
5.71
3968
19953
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
685
797
9.59
307.65
1.2
1.2
u/ml
45.6
0.6
—
24
6
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1302
1859
8.69
307.65
3.2
2.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
544
561
10.58
307.65
2.6
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4088
22014
3.76
307.65
12.4
5.7
%
2.7
2.9
4.63
3997
20307
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
742
292
28.91
307.65
2.2
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
562
711
8.63
307.65
1.5
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4393
24224
4.15
307.65
12.4
5.6
e9/l
0.2
0.2
2.50
4065
20860
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
582
774
8.23
307.65
1.3
1.2
u/ml
19.4
2.4
1.82
56
55
(3019069) Monocytes/100 leukocytes in Blood
4094
22123
3.75
307.65
12.9
6.1
%
8.9
8.9
0.01
4005
20468
(44790047)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
627
945
7.30
307.65
1.4
1.2
u/ml
12.8
6.3
1.21
140
145
(3037692) Legionella sp identified in Specimen by Organism specific culture
329
137
25.37
307.65
2.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1293
3755
4.13
307.65
4.8
4.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
638
1006
6.99
307.65
1.4
1.2
u/ml
41.3
46.7
0.14
35
52
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1838
6297
3.78
307.65
1.3
1.2
u/ml
29.2
13.2
2.68
534
2285
(3023419) Bacteria identified in Sputum by Culture
637
620
11.39
307.65
2.7
2.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1046
1121
11.12
307.65
1.9
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3488
16503
3.71
307.65
11.4
5.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
710
648
12.31
307.65
2.1
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
863
1418
6.95
307.65
1.3
1.2
u/ml
2.0
0.8
1.19
85
134
(44790049)
440
487
9.68
307.65
2.7
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
687
1226
6.21
307.65
2.4
2.2
g/l
128.7
127.4
0.35
269
929
(3013650) Neutrophils [#/volume] in Blood by Automated count
4424
27267
3.46
307.65
15.5
8.6
e9/l
4.7
4.3
28.25
4105
23577
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
611
948
7.07
307.65
1.4
1.2
titre
177.3
141.2
0.11
22
17
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1333
2001
8.31
307.65
1.6
1.6
u/ml
16.8
17.3
0.02
30
54
(3005719) IgG [Mass/volume] in Serum or Plasma
1298
3279
4.79
307.65
4.1
2.6
g/l
10.3
10.5
0.67
1237
2960
(3022096) Basophils/100 leukocytes in Blood
4056
21424
3.83
307.65
12.3
5.7
%
0.6
0.7
2.95
3973
19782
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
892
1161
8.87
307.65
2.3
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
618
1199
5.64
306.01
1.8
1.4
g/l
1.2
1.2
1.14
596
1126
(3005322) IgE [Units/volume] in Serum or Plasma
869
2254
4.35
303.66
1.6
1.2
u/ml
254.2
234.8
0.24
809
2043
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
415
540
8.19
301.48
3.5
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1413
5368
3.14
275.70
2.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2835
15526
2.58
272.19
6.1
4.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
209
107
20.21
271.68
1.3
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
311
332
9.83
263.81
2.0
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1174
4137
3.29
258.58
5.8
3.9
%
0.8
1.0
1.06
428
1251
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
287
286
10.49
255.83
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
286
284
10.53
255.57
2.1
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
190
97
20.20
247.17
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1083
3737
3.32
246.00
5.6
3.7
%
0.5
0.7
1.14
336
888
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
539
1125
5.17
244.59
1.8
1.9
mg/l
10.8
12.5
2.07
506
1026
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
149
39
39.16
243.66
3.1
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
323
429
7.91
229.90
2.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1040
3649
3.24
228.66
5.9
4.0
%
0.2
0.2
0.04
357
969
(3039162) Centromere protein B Ab [Units/volume] in Serum
324
441
7.71
225.74
1.3
1.2
u/ml
59.7
51.0
0.18
33
22
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3900
26091
2.45
224.92
10.0
6.1
umol/l
11.4
12.4
5.10
3787
24700
(3021440) Promyelocytes/100 leukocytes in Blood
1081
3931
3.14
223.35
5.9
3.9
%
0.1
0.1
1.17
398
1167
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
395
676
6.19
221.82
5.3
2.3
u/ml
694.4
2666.8
1.11
36
49
(3027135) IgG subclass 1 [Mass/volume] in Serum
298
377
8.27
220.92
1.4
1.3
g/l
7.7
6.7
2.18
204
257
(3028192) IgG subclass 2 [Mass/volume] in Serum
297
377
8.24
219.56
1.4
1.3
g/l
3.0
2.9
0.29
207
260
(3024139) IgG subclass 3 [Mass/volume] in Serum
297
377
8.24
219.56
1.4
1.3
g/l
0.5
0.4
2.27
205
260
(3016502) Oxygen saturation in Arterial blood
1388
5850
2.79
218.92
10.1
7.0
%
93.7
95.5
16.82
1344
5616
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
889
2907
3.42
218.63
10.8
8.8
mmol/l
24.6
24.3
2.42
819
2687
(4062490)
297
379
8.20
218.58
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
396
700
5.99
215.04
1.4
1.2
u/ml
60.4
46.0
0.75
61
64
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
320
455
7.38
214.40
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1217
4847
2.90
213.01
1.5
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
327
486
7.06
210.39
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
326
486
7.04
209.14
2.0
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3605
23729
2.33
209.12
9.6
6.1
mmol/l
1.2
1.2
4.77
3392
21304
(3024980) IgG subclass 4 [Mass/volume] in Serum
369
626
6.22
208.90
1.6
1.6
g/l
0.9
0.9
0.05
266
471
(3018418) pH of Serum or Plasma
2652
15427
2.30
205.92
5.6
4.0
ph
7.4
7.4
1.12
633
2912
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2859
17250
2.27
202.21
4.2
3.2
ng/l
1820.0
1801.8
0.06
2588
14992
(40760892) CBC W Ordered Manual Differential panel - Blood
1860
9398
2.43
198.77
8.9
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
433
892
5.16
198.67
4.6
3.6
%
59.6
58.3
1.05
433
892
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
251
304
8.58
192.65
1.3
1.1
u/ml
29.1
3.1
1.37
19
17
(3021589) Normoblasts [#/volume] in Blood
3204
20514
2.22
192.60
19.1
10.1
e9/l
0.0
0.0
0.69
2750
16625
(3042936) Bacteria identified in Isolate by Culture
1548
7292
2.52
191.84
2.6
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4636
34754
2.54
189.08
9.7
4.1
mm/h
18.4
13.9
54.39
4516
31677
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
255
324
8.18
188.14
1.3
1.1
u/ml
66.2
38.4
0.83
24
27
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
253
323
8.14
185.91
1.3
1.1
u/ml
65.8
82.7
—
9
15
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
234
273
8.88
185.01
4.2
3.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
256
334
7.97
184.69
1.3
1.1
u/ml
42.3
76.0
0.59
14
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3767
26165
2.21
178.97
10.5
6.8
mmol/l
1.2
1.2
1.45
3151
21935
(3007164) IgA [Mass/volume] in Serum or Plasma
1526
7542
2.38
167.00
1.9
1.5
g/l
2.8
2.6
2.57
1105
4344
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
710
2393
3.23
163.95
2.5
1.9
ug/l
2.3
2.7
0.20
646
2065
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
169
155
11.19
159.10
2.1
1.9
u/ml
61772.4
23010.6
0.26
22
22
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
348
767
4.76
146.76
1.4
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
867
3470
2.76
146.24
5.9
3.8
mmol/l
2.3
1.8
2.98
697
2536
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1804
10017
2.15
145.75
2.4
1.7
mg/l
1.6
1.4
0.88
1485
7775
(1616796) Gas panel - Central venous blood
456
1246
3.88
144.91
5.4
3.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
891
3640
2.70
144.25
6.1
3.8
kpa
5.2
5.2
0.10
846
3333
(3011412) CD3 cells [#/volume] in Blood
249
412
6.26
144.06
2.3
2.0
e9/l
1.0
1.1
1.72
176
238
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
344
764
4.72
143.69
1.3
1.4
u/ml
33.2
14.2
—
6
14
(3009343) pH of Capillary blood
882
3592
2.71
143.64
6.1
3.8
ph
7.4
7.4
4.47
154
441
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2355
14501
2.04
143.62
5.4
3.1
u/l
34.2
37.0
0.80
2256
13646
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
317
663
5.00
142.27
1.4
1.4
u/ml
132.2
122.7
0.18
66
138
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
809
3182
2.79
140.80
12.1
7.0
mmol/l
25.1
24.8
0.94
799
3152
(3042733) HLA Ab [Presence] in Serum
130
96
13.82
139.99
4.2
5.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1140
5318
2.42
139.31
11.4
7.4
g/l
123.8
120.1
6.64
1103
5123
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
445
1229
3.83
139.16
1.6
1.6
iu/ml
58.1
5.7
0.91
107
285
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4714
37528
2.25
136.32
14.6
7.6
u/l
78.6
80.9
2.71
4613
35088
(3036481) Cortisol [Moles/volume] in Serum or Plasma
935
4022
2.57
135.81
2.2
2.2
nmol/l
343.0
376.2
3.94
879
3673
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
154
161
9.79
132.17
3.6
1.7
ug/l
43.5
59.7
1.43
154
154
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
240
417
5.96
132.05
1.6
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
136
119
11.67
131.99
2.9
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
2018
12036
2.03
131.96
11.0
6.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
671
2476
2.93
131.12
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
903
3894
2.56
130.10
1.6
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1560
8497
2.13
130.10
6.7
3.1
mmol/l
0.8
0.8
1.04
1458
7858
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
204
308
6.82
128.90
2.2
2.0
%
16.2
13.9
0.88
81
128
(1175426) CD3 cells/100 lymphocytes in Blood
207
318
6.71
128.67
2.2
2.0
%
71.5
71.1
0.10
200
295
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
213
341
6.44
127.23
1.4
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2250
14079
1.96
127.14
4.7
3.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
182
253
7.39
124.01
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
182
256
7.30
122.71
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
197
302
6.71
122.68
2.3
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2468
16074
1.92
122.54
5.0
3.5
e6/l
95.0
108.8
0.11
2021
12595
(3024561) Albumin [Mass/volume] in Serum or Plasma
3179
22573
1.88
119.75
6.4
4.8
g/l
33.3
34.7
33.16
2969
20801
(40767503) Oxygen content in Capillary blood by calculation
412
1196
3.63
119.40
3.5
2.5
%
15.8
16.0
0.24
223
634
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
934
4248
2.42
119.25
1.5
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
421
1241
3.58
119.21
7.2
4.4
kpa
8.2
8.4
1.39
412
1210
(3024471) HLA-A [Type]
121
105
11.74
118.02
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2288
14677
1.91
117.74
4.8
3.3
e6/l
0.4
0.5
0.82
1830
11268
(3024932) HLA-DR beta [Type]
119
101
12.00
117.73
1.0
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3156
22458
1.87
117.03
12.7
11.0
inr
1.3
1.3
3.70
1064
6100
(3012501) Base excess in Blood by calculation
415
1235
3.54
115.76
7.2
4.4
mmol/l
2.8
2.7
0.28
319
836
(3013290) Carbon dioxide [Partial pressure] in Blood
415
1236
3.54
115.61
7.2
4.4
kpa
5.0
5.0
0.33
406
1206
(3018095) Leukocytes [#/volume] in Urine
2679
18167
1.87
115.19
5.9
3.9
e6/l
101.7
110.8
0.15
2087
13384
(3015235) Bicarbonate [Moles/volume] in Capillary blood
466
1512
3.26
113.26
4.9
3.0
mmol/l
25.3
24.9
1.26
428
1304
(3010421) pH of Blood
449
1436
3.30
111.70
7.0
4.3
ph
7.4
7.4
1.04
406
1208
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
420
1293
3.42
111.05
3.3
2.3
g/l
3.8
3.6
2.20
408
1225
(3026782) Osmolality of Urine
1776
10640
1.96
110.81
4.0
2.9
mosm/kgh2o
533.0
554.8
4.88
1594
9041
(3008152) Bicarbonate [Moles/volume] in Arterial blood
816
3609
2.46
110.23
8.7
6.6
mmol/l
25.1
24.5
4.46
778
3365
(3021901) Oxygen saturation in Capillary blood
380
1104
3.61
109.84
4.5
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1869
11426
1.93
109.55
3.9
2.7
e6/l
4.6
4.6
0.06
1700
10016
(21494815) CD4 cells/100 lymphocytes in Specimen
198
344
5.92
108.85
2.3
2.0
%
32.5
41.3
1.12
14
43
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1048
5210
2.23
107.83
4.2
3.0
ng/l
239.4
243.0
0.09
986
4780
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
146
186
8.02
107.23
1.5
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
426
1355
3.31
106.82
5.7
3.2
kpa
7.7
7.9
2.26
407
1250
(3013826) Glucose [Moles/volume] in Serum or Plasma
3875
29909
1.85
105.62
8.7
4.9
mmol/l
6.8
6.9
0.64
3731
28147
(3020779) Urea [Moles/volume] in Serum or Plasma
1032
5154
2.21
104.72
11.5
6.8
mmol/l
10.7
11.0
0.74
984
4868
(3010375) cycloSPORINE [Mass/volume] in Blood
140
176
8.12
103.96
44.3
23.2
ug/l
156.4
109.3
7.20
115
143
(3023420) DNA double strand Ab [Units/volume] in Serum
201
371
5.57
103.63
1.9
1.2
iu/ml
22.3
24.9
—
10
16
(40757373) Influenza virus identified in Isolate
112
109
10.45
101.11
2.9
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1194
6511
2.04
95.43
4.5
4.0
u/l
269.4
246.1
4.84
1131
6119
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1328
7524
1.99
95.29
2.9
2.6
%
20.7
21.9
2.70
1127
6335
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
238
550
4.47
94.27
1.3
1.2
u/ml
4.4
3.6
0.12
96
165
(3022948) Iron [Moles/volume] in Serum or Plasma
1462
8590
1.93
94.12
2.9
2.5
umol/l
11.5
12.3
4.92
1381
7887
(3009871) Measles virus Ab [Titer] in Serum
96
83
11.74
93.80
1.3
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
391
1278
3.20
93.53
3.4
2.2
%
89.6
88.4
0.50
375
1213
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
439
1542
2.99
92.75
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1378
7990
1.94
91.99
2.8
2.5
g/l
2.2
2.3
0.55
1285
7346
(4306422)
223
503
4.57
91.05
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
917
4606
2.17
90.67
12.2
7.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2697
19247
1.74
90.26
2.8
2.2
nmol/l
77.8
79.0
1.32
2480
16832
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
219
493
4.57
89.63
1.2
1.1
%
118.7
114.4
0.95
211
435
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
187
373
5.14
88.41
1.4
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
118
147
8.17
88.26
2.2
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1229
6963
1.97
87.25
11.8
6.7
mmol/l
103.8
104.4
4.03
1194
6801
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
226
535
4.35
86.76
1.3
1.2
u/ml
3.4
4.9
1.06
135
231
(3013293) Extractable nuclear Ab [Presence] in Serum
73
45
16.41
86.52
1.5
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
251
645
4.02
86.36
1.2
1.2
u/ml
344.1
288.6
1.14
164
380
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
153
260
6.01
86.00
1.5
1.3
u/ml
1.5
1.4
0.03
95
131
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
174
334
5.34
85.89
2.2
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
117
150
7.94
85.44
1.2
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
114
142
8.17
85.28
41.3
32.0
ug/l
8.1
7.3
2.18
103
127
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
170
323
5.39
84.87
1.1
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
938
4867
2.10
84.82
11.0
6.5
mmol/l
1.5
1.4
1.25
891
4662
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
806
3952
2.20
84.25
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4106
33273
1.76
83.87
6.8
4.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
821
4067
2.18
83.60
2.1
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
597
2591
2.45
82.89
6.4
4.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
170
331
5.26
82.59
1.3
1.2
titre
128.0
131.8
0.03
35
55
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
170
331
5.26
82.59
1.3
1.2
titre
112.7
130.0
0.20
11
12
(3020630) Protein [Mass/volume] in Serum or Plasma
933
4881
2.08
82.35
2.2
2.5
g/l
66.2
66.0
0.23
864
4364
(3028271) Lactate [Moles/volume] in Capillary blood
295
875
3.50
82.33
2.4
1.9
mmol/l
1.7
1.7
0.59
289
852
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
259
705
3.80
82.15
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
354
1181
3.12
81.63
3.6
2.4
%
210.2
203.6
0.64
337
1128
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
147
256
5.86
80.56
1.7
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
128
194
6.72
80.50
1.7
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
128
194
6.72
80.50
1.7
1.9
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
155
285
5.56
80.20
2.2
2.0
e6/l
471.2
524.9
0.48
128
235
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
128
195
6.69
80.11
1.7
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
659
3035
2.32
79.89
14.8
9.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1218
7075
1.91
79.40
7.9
5.7
mmol/l
1.1
1.0
0.72
1133
6515
(21494814) CD8 cells/100 lymphocytes in Specimen
119
170
7.12
79.05
2.1
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
145
256
5.78
78.34
1.7
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
350
1194
3.05
77.61
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
350
1194
3.05
77.61
1.5
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
210
515
4.19
76.93
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
165
335
5.04
76.42
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
297
929
3.31
76.16
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
177
383
4.73
76.02
1.2
1.2
%
96.5
94.2
0.47
172
358
(3036489) Thrombin time
426
1643
2.72
75.29
3.3
2.0
s
21.7
21.8
0.05
389
1481
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2276
16059
1.68
75.24
3.5
2.2
u/l
154.6
227.9
4.60
2149
14945
(3033658) Prothrombin time (PT) actual/Normal
1863
12498
1.72
74.16
6.4
4.0
%
84.4
84.8
0.31
1828
12203
(3026493) Urate [Moles/volume] in Serum or Plasma
1959
13351
1.70
73.39
4.9
2.8
umol/l
2219.4
5525.5
4.76
1724
11331
(3002032) Base excess in Venous blood by calculation
959
5289
1.97
72.28
4.9
3.7
mmol/l
2.3
1.9
2.09
797
4245
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1626
10582
1.74
71.78
5.4
4.1
ng/l
425.2
480.1
0.21
1444
8996
(4268621)
165
354
4.77
71.59
2.3
2.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
143
271
5.38
71.59
2.3
2.1
e9/l
0.2
0.2
0.12
126
235
(3021447) Carbon dioxide [Partial pressure] in Venous blood
956
5303
1.96
70.72
4.9
3.7
kpa
5.9
5.8
1.19
917
5135
(3008536) Aspergillus sp Ab [Presence] in Serum
84
90
9.45
70.71
1.6
1.7
—
—
—
0
0
(4015189)
102
139
7.45
70.67
2.1
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3017
23139
1.62
69.79
4.9
3.9
estimate
0.0
0.0
0.50
831
4277
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
171
386
4.53
69.71
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
890
4839
1.99
69.70
2.3
2.2
g/l
0.2
0.2
1.66
831
4470
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
704
3516
2.14
69.46
2.0
1.7
—
—
—
0
0
(3012544) pH of Venous blood
976
5492
1.93
69.06
4.8
3.7
ph
7.4
7.4
—
8
32
(3017569) Oxygen content in Arterial blood
144
284
5.17
68.95
2.2
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1152
6847
1.85
68.76
3.5
2.4
%
1.9
1.8
5.60
1020
6006
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
659
3249
2.16
67.10
1.7
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
3002
23134
1.60
67.01
6.7
5.3
estimate
0.0
0.0
0.50
839
4311
(3015377) Calcium [Moles/volume] in Serum or Plasma
2381
17378
1.62
66.47
4.3
3.4
mmol/l
2.3
2.3
3.06
2137
14850
(3009261) Glucose [Presence] in Urine by Test strip
3029
23458
1.60
65.70
5.0
4.0
estimate
0.0
0.0
1.60
816
4188
(3031040) Bacteria [#/volume] in Urine by Automated count
3943
32584
1.63
64.62
6.4
4.9
e6/l
744.1
1855.2
1.55
64
564
(3014007) Fractional oxyhemoglobin in Arterial blood
693
3538
2.09
64.28
14.2
8.5
%
92.3
93.9
9.82
687
3522
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
810
4389
1.98
63.65
5.0
4.0
mmol/l
1.2
1.2
2.75
739
3817
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
127
251
5.15
60.67
2.1
1.5
u/l
6.0
6.7
0.41
112
213
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
551
2638
2.20
60.15
4.9
3.9
mmol/l
24.4
24.1
1.49
496
2360
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
119
225
5.38
59.74
1.1
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
172
439
4.01
59.68
1.1
1.1
iu/ml
1.8
2.3
—
9
12
(3034426) Prothrombin time (PT)
85
117
7.36
58.38
1.1
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
674
3526
2.03
58.20
14.4
8.5
%
0.6
0.7
0.92
666
3497
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1311
8443
1.71
58.20
2.8
2.0
s
30.0
30.2
0.50
1281
8173
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1309
8442
1.71
57.75
4.2
3.2
e6/l
1.6
1.9
0.89
742
4798
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
672
3540
2.01
56.85
14.4
8.4
%
1.4
1.3
1.93
664
3516
(40761536) Microorganisms panel - Urine sediment
738
4044
1.94
55.66
5.3
4.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2663
20522
1.54
55.44
5.3
4.1
ng/l
104.5
80.1
0.15
2137
15666
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
64
66
9.79
55.39
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
459
2107
2.28
55.37
3.9
2.8
u/ml
0.3
0.3
0.75
281
1191
(3023520) Reticulocytes [#/volume] in Blood
888
5198
1.83
54.49
3.4
2.5
e9/l
73.3
67.8
3.43
623
3972
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
120
248
4.92
54.46
2.5
2.6
%
39.1
36.1
0.65
54
90
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2499
19085
1.54
53.64
3.4
2.9
ug/l
201.8
156.1
7.34
2294
17286
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
73
93
7.93
53.59
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
74
98
7.63
52.57
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
136
323
4.29
51.98
2.6
2.3
ph
7.4
7.4
0.39
83
107
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
88
144
6.19
51.41
2.2
2.0
%
30.4
30.0
0.07
83
131
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1901
13764
1.56
51.40
2.6
2.3
mg/l
3.3
3.1
2.80
1673
11619
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
188
569
3.38
50.74
1.1
1.1
g/l
1.6
1.6
0.03
166
508
(3006245) CD3-CD19+ cells/100 cells in Blood
87
143
6.16
50.60
2.2
2.0
%
9.6
12.4
0.79
80
126
(3002385) Erythrocyte distribution width [Ratio]
4246
36580
1.57
50.41
38.1
20.4
%
14.3
13.9
62.24
4209
35681
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
127
297
4.35
49.53
2.4
2.0
e6/l
634.8
600.8
0.19
57
128
(3020891) Body temperature
467
2259
2.16
49.38
5.8
4.6
—
—
—
0
0
(4035726)
763
4390
1.85
49.14
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
915
5593
1.75
48.02
5.0
3.7
—
—
—
0
0
(3015736) pH of Urine
2370
18192
1.50
47.98
4.2
3.7
—
5.8
—
0
18
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1333
9032
1.61
47.16
3.9
3.0
e6/l
1.0
1.2
1.23
769
5346
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
52
51
10.28
46.62
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
475
2370
2.09
46.26
6.0
4.9
%
1.8
1.6
3.88
448
2219
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
246
924
2.73
45.52
1.4
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
448
2221
2.10
44.33
7.3
4.3
mmol/l
25.1
24.8
1.33
426
2022
(3047181) Lactate [Moles/volume] in Blood
373
1721
2.25
44.26
8.4
5.8
mmol/l
1.4
1.3
0.64
343
1521
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
889
5507
1.72
44.19
3.1
2.7
umol/l
10.5
9.3
0.64
776
4802
(3024354) Oxygen [Partial pressure] in Venous blood
739
4351
1.80
43.83
3.8
3.1
kpa
4.5
4.5
0.07
705
4197
(3004809) Band form neutrophils/100 leukocytes in Blood
245
945
2.66
43.04
4.1
3.6
%
1.5
1.5
0.01
214
701
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2835
22926
1.45
42.16
3.0
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
268
1092
2.52
42.08
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
95
201
4.79
41.98
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
236
907
2.67
41.75
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
299
1299
2.37
40.81
1.5
1.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
37
26
14.31
40.76
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
523
2822
1.94
40.73
1.9
1.7
g/l
1.6
1.6
0.68
439
2404
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
398
1948
2.12
40.66
3.5
2.2
ug/l
387.3
638.7
1.18
377
1847
(3034860) Kappa light chains.free [Mass/volume] in Serum
397
1948
2.11
40.29
2.5
3.2
mg/l
62.0
92.4
0.52
287
1612
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
396
1944
2.11
40.13
2.5
3.2
mg/l
43.4
54.6
0.75
285
1609
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
89
187
4.82
39.66
1.2
1.2
ratio
1.1
1.1
0.09
34
61
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
386
1900
2.10
38.83
2.5
3.2
ratio
4.1
3.5
0.12
25
148
(3041096) Erythrocytes [Presence] in Urine by Automated
1635
12021
1.50
38.82
5.0
3.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
253
1043
2.49
38.74
1.9
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
230
917
2.57
37.78
1.7
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
75
142
5.34
37.66
1.1
1.1
u/ml
27.9
6.6
—
10
14
(3052851) Hemolysis interference index of Serum or Plasma
340
1612
2.18
37.65
4.4
3.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
402
2050
2.03
36.72
4.7
3.8
mmol/l
1.4
1.4
0.27
396
2016
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
353
1716
2.12
36.66
2.4
2.2
g/l
0.1
0.1
0.10
327
1551
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
150
483
3.16
36.65
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
443
2342
1.96
36.53
6.4
5.0
%
0.9
0.9
0.26
415
2197
(3029937) Albumin [Presence] in Urine by Test strip
1708
12802
1.47
36.35
5.4
4.4
estimate
0.0
0.0
0.88
779
4075
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
332
1591
2.15
35.76
2.4
2.2
g/l
0.0
0.0
1.04
306
1431
(3018572) Chloride [Moles/volume] in Blood
279
1246
2.30
35.71
8.4
6.7
mmol/l
103.8
105.1
4.84
256
1112
(3039000) Anion gap in Blood
279
1246
2.30
35.71
8.4
6.6
mmol/l
11.7
11.2
1.76
256
1112
(3007853) Bacteria identified in Skin by Aerobe culture
899
5882
1.62
35.60
2.2
1.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
327
1561
2.16
35.57
2.4
2.2
g/l
0.0
0.0
0.00
306
1425
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
413
2152
1.99
35.49
2.4
2.3
g/l
3.3
3.1
4.10
334
1666
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2324
1.95
35.07
2.3
2.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
414
2168
1.98
35.06
2.4
2.3
g/l
10.6
10.2
0.75
353
1806
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
436
2326
1.94
34.98
2.3
2.3
g/l
7.9
7.4
4.37
338
1690
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
435
2320
1.94
34.93
2.3
2.3
g/l
3.9
3.8
0.34
330
1628
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2020
15725
1.43
34.79
3.0
2.6
u/l
61.5
58.8
0.41
1885
14450
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5003
45941
1.57
33.74
34.8
16.9
mg/l
25.3
26.9
3.44
4687
37477
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
380
1960
2.00
33.58
2.4
2.3
g/l
0.7
1.0
0.98
337
1655
(3026008) Bacteria identified in Urine by Culture
2035
15962
1.42
33.20
3.8
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
236
1012
2.39
33.16
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
352
1793
2.02
32.20
2.4
2.1
g/l
35.9
37.4
4.53
319
1503
(3029075) Extractable nuclear Ab panel - Serum
57
97
5.92
32.07
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
3840
33639
1.40
32.01
5.8
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
141
476
3.01
31.81
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
299
1460
2.10
30.65
2.4
3.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
55
98
5.66
29.52
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
962
6652
1.53
29.50
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
245
1125
2.23
29.35
1.2
1.2
titre
107.1
93.9
0.22
28
71
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1343
9987
1.45
28.56
3.0
3.1
mmol/l
2.5
2.5
8.49
1192
8699
(3034770) Mitochondria Ab [Titer] in Serum
244
1133
2.20
28.44
1.2
1.2
titre
977.5
966.3
0.01
12
35
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
323
1697
1.96
27.02
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
164
657
2.54
26.73
1.1
1.3
miu/ml
195.3
206.7
0.11
23
239
(3011397) Hemoglobin [Presence] in Urine by Test strip
1469
11217
1.41
26.69
4.3
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
282
1434
2.01
25.90
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3222
27921
1.34
25.74
4.4
3.1
u/l
66.1
55.2
5.01
2995
25352
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2167
17718
1.35
25.60
5.3
4.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
550
3444
1.66
25.48
4.7
3.3
g/l
125.8
127.6
1.12
531
3355
(3000060) B lymphocytes [#/volume] in Blood
50
94
5.36
25.37
2.3
1.9
e6/l
958.8
1629.0
0.21
25
40
(3043409) Potassium [Moles/volume] in Arterial blood
321
1727
1.91
25.02
5.4
4.1
mmol/l
4.0
3.9
2.49
293
1606
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1147
8481
1.44
24.68
1.3
1.2
u/ml
1.1
1.7
3.18
291
2095
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
115
404
2.88
24.24
1.8
1.8
mg/l
4.5
4.6
0.06
107
385
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
50
98
5.14
24.23
1.1
1.1
%
89.0
82.0
0.70
32
53
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
63
150
4.23
24.14
1.3
2.1
%
197.5
167.9
1.17
57
141
(3036782) Glucose [Moles/volume] in Pleural fluid
150
613
2.48
23.49
1.5
1.4
mmol/l
6.6
6.4
0.30
136
565
(3051651) Icteric interference index of Serum or Plasma
97
315
3.11
23.48
5.8
3.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
52
109
4.80
23.34
1.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
58
133
4.39
23.33
2.4
2.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
249
1267
2.01
22.84
3.5
3.0
mg/l
1.8
1.7
0.64
230
1125
(3008757) Leukocyte morphology finding [Identifier] in Blood
148
611
2.46
22.68
4.9
4.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
398
2358
1.74
22.60
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
156
661
2.40
22.59
1.2
1.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
29
9
32.37
22.37
1.0
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
148
616
2.44
22.29
1.7
1.5
%
59.1
62.4
0.45
89
406
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
49
102
4.84
22.18
1.1
1.3
%
89.7
80.4
0.82
34
58
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
667
4517
1.54
22.08
2.7
2.4
u/l
36.2
48.1
0.57
605
3840
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
123
471
2.65
22.04
1.9
1.4
%
39.1
26.1
3.17
72
301
(3027273) Bicarbonate [Moles/volume] in Venous blood
455
2825
1.66
21.70
4.6
3.4
mmol/l
25.6
25.1
2.07
430
2738
(3003327) Ova and parasites identified in Stool by Light microscopy
235
1201
2.00
21.31
1.9
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
262
1406
1.90
20.59
1.6
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
118
459
2.60
20.52
1.7
1.5
u/l
14.2
13.2
0.73
113
439
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
48
105
4.60
20.50
1.6
1.4
ug/l
8.2
9.4
0.96
48
105
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
605
4080
1.54
20.35
1.7
1.7
%
1.7
1.6
2.04
509
3442
(3045142) Bone marrow Pathology biopsy report
143
613
2.37
20.21
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
240
1262
1.94
20.05
1.8
1.6
e6/l
13794.1
14620.8
0.09
182
913
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
42
85
4.97
19.67
1.5
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
393
2409
1.68
19.67
2.7
1.9
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
74
228
3.27
19.60
1.7
1.4
%
3.9
4.0
0.05
20
58
(3045716) Anion gap in Serum or Plasma
80
259
3.12
19.53
2.1
2.2
mmol/l
8.5
9.4
1.34
63
206
(3023183) Ammonium ion [Moles/volume] in Plasma
218
1124
1.98
19.30
2.7
2.5
umol/l
33.3
34.7
0.32
192
937
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
38
72
5.31
19.16
1.2
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1432
11387
1.34
19.14
1.9
1.8
nmol/l
1187.6
1163.4
0.40
1086
8497
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
120
489
2.48
18.98
1.3
1.3
u/l
14.8
13.4
0.25
108
448
(3004451) EKG impression Narrative
86
296
2.93
18.90
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
198
1003
2.01
18.44
1.8
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
152
699
2.21
18.25
1.6
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
142
636
2.26
18.17
1.4
1.3
u/l
482.0
378.6
0.61
131
600
(3044941) Cell count panel - Synovial fluid
168
814
2.09
17.67
1.8
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
469
3082
1.57
17.65
3.3
3.3
e9/l
4.6
4.2
1.96
374
2208
(3003434) Protein [Mass/volume] in Pleural fluid
183
918
2.03
17.53
1.5
1.5
g/l
32.6
31.3
0.63
158
820
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
161
770
2.12
17.52
1.2
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
406
2588
1.61
17.39
3.9
2.7
%
0.7
0.7
0.78
398
2478
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
36
71
5.10
17.38
1.1
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2226
18974
1.28
17.38
2.4
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1594
13023
1.31
17.27
1.8
1.6
nmol/l
18.9
20.1
2.41
1423
11023
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
78
268
2.94
17.23
4.0
3.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
156
743
2.13
17.17
8.1
6.3
mg/l
12.0
12.0
0.10
145
682
(3016650) Hepatitis A virus Ab [Presence] in Serum
137
621
2.23
17.06
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
40
88
4.57
17.01
1.6
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
86
314
2.76
16.99
1.7
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
171
854
2.03
16.60
2.9
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
121
533
2.30
16.15
1.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
130
592
2.22
16.03
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
638
4585
1.44
15.49
2.3
2.1
ug/g
194.6
164.4
0.97
522
3557
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
22
30
7.36
15.24
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
131
615
2.16
15.01
1.6
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
112
493
2.30
15.00
1.1
1.2
u/l
56.8
63.5
0.57
90
326
(40768806) Pleura Pathology biopsy report
144
703
2.07
14.91
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
275
1651
1.70
14.90
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
85
331
2.59
14.86
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
206
1141
1.83
14.74
3.9
2.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
123
568
2.19
14.69
5.4
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
106
462
2.32
14.54
1.3
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
60
196
3.08
14.53
4.2
3.8
%
60.6
54.5
1.30
60
189
(3000570) Elastase.pancreatic [Mass/mass] in Stool
250
1477
1.72
14.37
1.4
1.5
ug/g
290.2
264.9
0.43
156
890
(40768446) Kidney Pathology biopsy report
52
158
3.31
14.18
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
570
4101
1.43
13.70
4.3
3.8
ng/l
104.9
96.9
0.81
495
3456
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
557
3992
1.44
13.68
3.8
2.8
ml/min/173m2
56.7
60.9
1.93
268
1695
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
35
83
4.24
13.59
1.7
1.8
mg/l
6.2
9.0
2.03
29
69
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
342
2227
1.57
13.39
2.3
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
32
72
4.46
13.28
1.3
1.2
ng/l
120.2
1242.3
0.50
21
48
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3691
33920
1.23
13.14
4.1
3.8
pmol/l
15.0
15.0
0.26
3333
30180
(3032743) Legionella sp IgG Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
20
30
6.69
12.73
1.2
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
147
769
1.93
12.60
1.6
1.9
ug/l
23.1
23.8
0.06
142
751
(3050794) Legionella sp Ab [Presence] in Serum
23
41
5.63
12.40
1.1
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
29
66
4.41
11.89
1.0
1.2
%
93.4
75.8
—
10
24
(3044927) Protein electrophoresis panel - Urine
124
625
2.01
11.85
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
226
1375
1.67
11.71
3.0
3.1
nmol/l
0.9
0.8
0.38
176
1033
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2552
22747
1.21
11.70
5.2
4.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
15
9.35
11.65
1.4
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
44
5.24
11.52
1.0
1.0
—
—
—
0
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
5.2
2.2
—
6
10
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
3.4
2.7
—
7
11
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.5
3.5
—
9
12
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
1.3
1.3
—
6
12
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
0.8
0.9
—
7
11
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.2
3.3
—
6
10
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
6.2
1.2
—
5
12
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
18
8.35
11.48
1.6
1.2
mg/l
2.8
0.6
—
8
11
(3040151) Glucose [Moles/volume] in Capillary blood
130
674
1.95
11.48
15.0
18.6
mmol/l
7.5
7.5
0.06
114
555
(3010726) Horse dander IgE Ab [Units/volume] in Serum
77
326
2.38
11.37
1.1
1.1
u/ml
2.6
1.5
0.38
29
85
(3023430) Cat dander IgE Ab [Units/volume] in Serum
65
255
2.57
11.29
1.0
1.1
u/ml
1.6
3.3
0.84
34
102
(3023199) Leukocytes [#/volume] in Pleural fluid
148
806
1.86
11.27
1.6
1.5
e6/l
4879.0
1826.6
0.62
100
585
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
69
279
2.49
11.26
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
75
317
2.38
11.13
2.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
78
336
2.34
11.09
1.4
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
68
276
2.48
11.02
1.0
1.1
u/ml
3.5
2.6
0.24
34
113
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
19
7.91
11.00
1.6
1.3
mg/l
0.2
2.2
—
5
13
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
28
66
4.26
11.00
1.1
1.2
%
77.0
82.1
—
9
23
(3028308) Erythrocytes [#/volume] in Pleural fluid
136
727
1.89
10.98
1.6
1.5
e6/l
128625.3
60188.1
0.95
78
430
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
94
443
2.14
10.79
1.1
1.1
u/ml
1.5
2.4
0.41
48
180
(3035880) pH of Pleural fluid
83
372
2.25
10.78
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1371
11542
1.24
10.74
1.8
1.7
pmol/l
39405345.0
26490209.3
0.27
1109
9347
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
45
150
3.02
10.62
1.1
1.1
u/ml
14.3
2.3
1.08
11
20
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
193
1158
1.69
10.57
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
72
307
2.36
10.50
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
682
5273
1.33
10.46
2.6
2.4
ug/l
10.9
6.8
4.17
597
4536
(3009508) Creatinine [Moles/volume] in Urine
1880
16394
1.21
10.44
3.6
3.2
mmol/l
7.1
7.4
1.79
1559
13483
(3017354) Segmented neutrophils/100 leukocytes in Blood
114
586
1.96
10.36
4.6
3.5
%
54.5
59.4
1.39
83
352
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
68
285
2.40
10.31
1.1
1.2
u/l
95.8
92.6
0.10
62
243
(3022493) Free Hemoglobin [Mass/volume] in Plasma
57
220
2.61
10.27
5.9
4.5
mg/l
61.9
69.0
0.45
45
150
(3003888) Timothy IgE Ab [Units/volume] in Serum
84
387
2.19
10.22
1.1
1.1
u/ml
3.9
3.8
0.03
48
185
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
66
274
2.42
10.22
1.1
1.2
u/l
44.2
24.9
1.25
60
229
(44806071)
21
42
5.01
10.03
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
123
659
1.88
9.90
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1836
16045
1.21
9.84
3.6
3.2
mg/l
682.9
316.7
2.02
1234
10292
(40768443) Skin Pathology biopsy report
325
2243
1.48
9.74
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
45
159
2.84
9.61
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2459
22108
1.19
9.61
2.2
2.1
pmol/l
91.3
93.1
1.06
1336
11609
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
11
10.02
9.54
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
136
762
1.80
9.52
1.1
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
54
4.27
9.11
1.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
19
38
5.01
9.08
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
641
5013
1.31
9.04
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
55
223
2.48
9.00
1.0
1.0
u/ml
0.2
0.3
0.18
23
72
(40761511) CBC panel - Blood by Automated count
4887
46874
1.24
8.97
27.3
16.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1816
15975
1.20
8.87
3.2
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
48
184
2.62
8.82
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
20
43
4.66
8.81
1.5
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
73
339
2.17
8.77
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4209
39821
1.20
8.68
34.0
18.2
%
38.8
38.8
0.16
2670
25221
(3022145) Colonoscopy Study observation
663
5263
1.29
8.35
1.3
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
39
139
2.82
8.25
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
92
477
1.94
8.24
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1909
16964
1.18
8.16
4.5
4.0
mg/mmol
12.8
9.7
1.53
1240
10779
(3008401) Mugwort IgE Ab [Units/volume] in Serum
77
377
2.06
8.10
1.1
1.1
u/ml
0.5
1.4
1.35
37
162
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
516
6618
0.76
8.08
9.8
8.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
11
14
7.87
7.98
1.8
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
65
302
2.17
7.84
1.4
1.6
u/l
8.9
6.4
0.60
37
140
(3006576) Bicarbonate [Moles/volume] in Blood
46
184
2.51
7.80
5.7
6.8
mmol/l
24.5
24.6
0.03
39
165
(36660697) Celiac disease serology panel - Serum
411
3078
1.36
7.79
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
55
239
2.31
7.79
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
55
240
2.30
7.72
1.1
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5004
48291
1.23
7.65
35.7
20.1
mmol/l
139.0
139.6
47.10
4943
46988
(3036603) Volume of Urine
68
325
2.10
7.65
1.4
1.7
ml
1834.5
1813.2
0.04
19
87
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
12
8.35
7.58
1.1
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
49
207
2.38
7.41
1.3
1.3
mmol/l
3.7
3.5
0.15
43
186
(3022217) INR in Platelet poor plasma by Coagulation assay
970
8167
1.22
7.30
29.9
29.5
inr
1.5
1.5
0.04
102
1144
(3006922) Hepatitis E virus Ab [Presence] in Serum
56
253
2.23
7.27
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
720
5881
1.26
7.16
3.2
4.0
ug/l
14.2
23.6
1.16
594
4872
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
20
51
3.93
7.15
1.6
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5006
48382
1.22
7.13
36.0
20.3
mmol/l
4.0
4.0
3.30
4938
47011
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
76
389
1.97
7.13
1.6
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
10
13
7.70
7.12
1.1
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
70
3.44
7.10
1.4
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
100
562
1.79
7.04
2.6
3.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
76
394
1.94
6.88
1.6
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
153
972
1.59
6.83
1.4
1.3
mmol/l
66.0
62.5
0.51
138
780
(3014765) Yersinia sp identified in Stool by Organism specific culture
192
1289
1.51
6.70
1.3
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
49
217
2.27
6.69
1.4
1.4
%
1.4
2.5
0.78
36
183
(42529406) Shigella sp [Presence] in Stool by Culture
193
1298
1.50
6.68
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
59
287
2.07
6.40
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
59
287
2.07
6.40
1.7
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
30
107
2.81
6.40
1.3
1.5
%
4.0
6.0
0.57
16
51
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
34
130
2.62
6.37
6.4
7.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4345
41594
1.17
6.30
5.1
4.7
mu/l
2.1
2.1
0.09
3964
37219
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
379
2901
1.33
6.25
2.6
2.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
188
1277
1.49
6.23
1.3
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
33
126
2.63
6.21
5.2
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1385
12217
1.17
6.15
3.1
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
311
2317
1.36
6.15
2.6
3.3
pmol/l
4.2
4.4
1.72
267
2014
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
68
355
1.93
6.08
1.1
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
20
58
3.46
6.00
1.3
1.0
iu/ml
6.3
6.9
0.10
12
23
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
45
203
2.23
5.93
1.1
1.1
iu/ml
7.6
13.4
—
6
49
(3041918) Cholesterol [Moles/volume] in Pleural fluid
32
124
2.59
5.86
1.2
1.2
mmol/l
2.0
1.6
1.10
15
81
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
515
6350
0.79
5.84
4.7
4.8
%
32.4
33.1
0.69
377
4127
(44813793)
50
237
2.12
5.84
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
27
96
2.82
5.82
1.3
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
174
2.31
5.74
3.4
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
174
2.31
5.74
3.4
2.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
54
268
2.02
5.60
1.4
1.4
%
60.3
68.9
0.78
36
218
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
21
66
3.19
5.58
1.5
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4989
48434
1.19
5.53
20.7
11.1
u/l
24.8
25.6
2.58
4922
46304
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
57
290
1.97
5.53
2.4
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
163
1104
1.49
5.52
1.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
84
486
1.74
5.45
1.1
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
41
186
2.21
5.36
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
58
301
1.94
5.33
2.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
85
498
1.72
5.29
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
140
929
1.52
5.25
1.2
1.3
u/l
45.5
40.3
0.12
123
803
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
148
994
1.50
5.24
1.1
1.1
u/ml
19.8
8.5
0.66
11
78
(3037121) Protein [Mass/volume] in Urine
249
1847
1.36
5.12
2.8
3.0
g/l
0.4
0.3
0.73
126
779
(21494755) Public health laboratory ask at order entry panel
137
2017
0.67
5.06
1.3
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
27
4.45
5.03
1.4
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
30
122
2.47
5.03
1.7
1.5
ug/l
0.3
0.4
0.57
23
67
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4470
43109
1.15
5.01
6.9
6.5
mmol/mol
41.5
40.8
3.91
4136
39177
(3044416) Complement C4 [Mass/volume] in Pleural fluid
14
36
3.90
4.98
1.1
1.1
g/l
0.1
0.1
—
7
28
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
49
246
2.00
4.97
1.2
1.1
u/l
94.4
92.6
0.04
41
182
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
49
246
2.00
4.97
1.2
1.1
u/l
33.4
35.5
0.07
40
177
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
104
655
1.60
4.93
1.6
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
59
317
1.87
4.92
1.0
1.0
mg/l
293.8
285.3
0.41
54
279
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4458
43008
1.15
4.89
29.3
16.1
ml/min/173m2
73.4
74.2
1.50
4026
35673
(3020491) Glucose [Moles/volume] in Blood
65
363
1.80
4.80
2.1
2.2
mmol/l
7.5
6.8
1.05
53
238
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
165
2322
0.70
4.79
1.9
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
104
661
1.58
4.76
1.6
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
17
52
3.28
4.74
2.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
103
655
1.58
4.71
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
103
655
1.58
4.71
1.6
1.4
—
—
—
0
0
(3013512) EKG study
1699
15475
1.14
4.66
5.2
4.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
103
657
1.58
4.65
1.6
1.4
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
14
38
3.69
4.64
1.3
1.3
ml/s/173m2
0.8
0.8
—
8
25
(3016750) Collection duration of Urine
58
318
1.83
4.56
2.2
2.0
min
476.0
493.3
0.52
37
221
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
19
64
2.98
4.55
1.3
1.3
nmol/l
12.0
146303.6
0.49
14
54
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
104
670
1.56
4.51
1.6
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
30
129
2.33
4.49
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
27
111
2.44
4.45
6.2
7.8
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
21
76
2.77
4.44
1.5
1.4
%
71.1
74.5
0.19
15
63
(44786800) Granulocytes/100 leukocytes in Body fluid
24
94
2.56
4.37
1.3
1.3
%
18.8
21.3
0.11
13
67
(3002523) Influenza virus A Ag [Presence] in Specimen
68
397
1.72
4.35
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
46
239
1.93
4.28
1.5
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
18
61
2.96
4.27
1.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
36
171
2.11
4.27
1.4
1.4
%
23.7
21.4
0.16
23
139
(3045424) Erythrocytes [Presence] in Urine
122
826
1.49
4.23
1.8
1.5
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
18
62
2.91
4.16
1.6
1.2
ug/l
102.4
119.6
—
10
36
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
18
62
2.91
4.16
1.3
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
18
62
2.91
4.16
2.1
1.4
umol/l
41.7
42.7
0.06
18
62
(3010144) Erythrocytes [#/volume] in Synovial fluid
82
510
1.62
4.15
1.7
1.3
e6/l
105988.9
109439.8
0.02
56
357
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
160
2.13
4.14
5.6
1.8
umol/l
152.9
130.5
0.18
21
98
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
57
2.99
4.11
1.1
1.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
47
250
1.89
4.10
1.7
2.4
ml
1994.8
1890.3
0.37
39
209
(21494890) Protein electrophoresis panel - 24 hour Urine
96
623
1.55
4.07
1.5
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
224
1698
1.33
4.07
1.4
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
67
398
1.69
4.06
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
45
237
1.91
4.05
1.5
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
68
407
1.68
4.01
5.8
2.3
%
10.8
10.9
0.08
68
407
(3016038) Potassium [Moles/volume] in Urine
62
365
1.71
3.89
1.3
1.1
mmol/l
32.5
34.4
0.33
57
306
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
68
419
1.63
3.62
1.9
1.9
u/l
5101.3
2495.0
0.27
20
157
(3005011) Chlamydia sp Ab [Titer] in Serum
15
51
2.95
3.57
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
102
1477
0.69
3.56
1.6
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
58
345
1.69
3.54
3.0
2.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
80
517
1.55
3.51
1.4
1.3
mosm/kgh2o
272.1
277.6
1.25
70
387
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
39
208
1.88
3.43
1.2
1.3
ug/l
118.5
530.0
1.07
15
108
(3020393) Adenovirus Ag [Presence] in Stool
14
47
2.98
3.41
1.2
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
47
2.98
3.41
3.6
2.6
mg/l
0.7
1.1
—
7
35
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
9
18
5.01
3.36
7.3
8.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
21
89
2.36
3.31
1.3
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
40
219
1.83
3.26
1.3
1.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
54
2.78
3.25
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1339
12259
1.12
3.22
1.8
1.6
mmol/l
1.4
1.3
3.75
1098
10155
(3044009) aPTT.lupus sensitive (LA screen)
10
28
3.58
3.19
1.4
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
10
28
3.58
3.19
1.5
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
50
295
1.70
3.18
1.7
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
190
1.85
2.96
2.9
2.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
17
4.71
2.91
1.6
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
50
303
1.66
2.91
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
79
1150
0.68
2.90
1.7
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
14
52
2.70
2.88
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
93
651
1.44
2.85
1.6
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
22
103
2.14
2.80
1.2
1.2
mg/l
0.8
97.1
0.80
14
77
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
498
4318
1.17
2.73
1.7
1.6
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
98
2.15
2.70
1.3
1.2
mmol/l
0.5
1.9
1.28
12
67
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
10
6.01
2.69
1.3
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1273
11736
1.11
2.66
1.5
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
25
127
1.97
2.59
1.0
1.1
miu/ml
1727.0
1647.2
0.10
25
127
(3004775) Volume in Urine collected for unspecified duration
68
458
1.49
2.56
2.3
2.2
ml
589.9
649.6
0.62
45
280
(3016135) IgD [Mass/volume] in Serum
5
7
7.15
2.55
1.4
1.3
mg/l
242.2
121.5
—
5
7
(3017446) Testosterone [Moles/volume] in Serum or Plasma
420
3616
1.17
2.53
2.6
2.1
nmol/l
12.3
12.0
0.30
360
3113
(3034274) Bile acid [Moles/volume] in Serum --fasting
38
224
1.70
2.49
1.1
1.6
umol/l
5.7
11.0
1.10
28
150
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
26
3.47
2.48
1.1
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
21
3.81
2.46
1.6
1.1
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
19
89
2.14
2.44
1.3
1.2
u/l
383.8
415.8
0.03
12
63
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
64
431
1.49
2.43
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
189
1513
1.26
2.41
1.6
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1650
17567
0.92
2.41
4.2
4.7
%
21.8
22.2
0.41
750
9298
(3000330) Specific gravity of Urine by Test strip
234
2838
0.82
2.40
4.9
3.7
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
5
8
6.25
2.37
2.6
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
58
2.42
2.36
4.1
4.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.64
2.36
2.1
5.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
41
252
1.63
2.32
1.6
1.3
nmol/l
1.2
1.2
0.11
31
189
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
18
3.89
2.25
1.3
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
18
3.89
2.25
1.3
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
9
5.56
2.21
2.4
4.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
31
181
1.72
2.14
1.2
1.2
g/l
32.3
40.7
2.07
14
89
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
74
2.17
2.14
1.3
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
88
2.05
2.11
2.4
1.4
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
11
43
2.56
2.09
1.3
1.2
mmol/l
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
103
778
1.33
2.09
1.4
1.4
u/l
10.1
10.5
0.12
82
629
(40758292) HTLV I+II Ab panel - Serum
14
62
2.26
2.07
1.2
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1124
10425
1.10
2.06
5.3
4.4
kg/l
1.0
1.0
0.04
204
1619
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
24
132
1.82
2.03
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
50
2.40
2.02
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
58
826
0.70
2.00
1.7
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
260
2201
1.19
1.98
1.2
1.2
iu/ml
118.8
139.2
0.38
77
771
(3035941) MCH [Entitic mass]
5069
49938
1.10
1.97
45.2
24.7
pg
30.5
30.4
0.49
5025
48989
(3024731) MCV [Entitic volume]
5069
49938
1.10
1.97
45.3
24.7
fl
92.5
91.6
27.56
5023
48989
(3007461) Platelets [#/volume] in Blood
5068
49929
1.10
1.96
45.5
24.8
e9/l
245.2
240.5
4.98
4986
48388
(3026361) Erythrocytes [#/volume] in Blood
5069
49941
1.10
1.95
45.5
24.8
e12/l
4.4
4.4
15.05
4970
48215
(3010813) Leukocytes [#/volume] in Blood
5070
49953
1.10
1.95
45.5
24.8
e9/l
7.8
6.9
68.46
4974
48215
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
39
2.57
1.92
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
39
2.57
1.92
1.3
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
15
71
2.12
1.92
1.2
1.2
u/l
19.4
19.4
—
8
49
(3000963) Hemoglobin [Mass/volume] in Blood
5069
49953
1.10
1.90
45.8
25.0
g/l
131.3
133.7
23.52
5024
49013
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
331
1.48
1.90
1.4
1.3
promille
1.1
1.2
0.08
38
251
(3044290) Cell count panel - Cerebral spinal fluid
110
852
1.30
1.89
1.2
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
29
173
1.68
1.89
2.2
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
104
800
1.31
1.89
1.4
1.4
iu/l
33.5
30.4
0.38
80
683
(3019174) dRVVT (LA screen)
8
28
2.86
1.86
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
33
205
1.61
1.85
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
23
129
1.79
1.85
1.9
2.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
35
2.57
1.80
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
26
153
1.70
1.79
1.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
44
295
1.50
1.79
1.7
1.8
u/field
1.5
2.8
0.75
34
203
(3038177) Helicobacter pylori Ab [Presence] in Serum
77
572
1.35
1.79
1.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
322
2801
1.16
1.78
2.4
2.4
au/ml
53.7
26.3
—
6
103
(1761482) Bacteria [#/volume] in Urine by Culture
126
1572
0.80
1.77
5.8
4.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
32
200
1.60
1.76
1.1
1.2
%
60.7
62.5
—
6
27
(3052592) Norovirus Ag [Presence] in Stool
22
124
1.78
1.75
2.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
292
2526
1.16
1.75
1.3
1.3
au/ml
44.8
58.3
—
8
104
(3040893) Potassium [Moles/volume] in Capillary blood
6
18
3.34
1.74
2.8
1.9
mmol/l
4.3
4.4
—
6
18
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
395
0.61
1.69
2.0
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
92
709
1.30
1.68
2.8
2.1
mg/l
24.2
25.7
0.11
31
169
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
203
1.58
1.67
1.3
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
62
452
1.38
1.64
1.5
1.6
u/ml
14.2
25.9
—
10
105
(3035637) Corticotropin [Mass/volume] in Plasma
76
573
1.33
1.63
1.6
1.5
—
—
—
0
0
(4027681)
30
189
1.59
1.62
1.2
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
26
2.69
1.58
1.0
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
22
129
1.71
1.56
1.3
1.3
g/l
0.4
0.3
1.17
14
101
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
17
92
1.85
1.55
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
43
297
1.45
1.55
2.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
37
249
1.49
1.52
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
49
679
0.72
1.51
1.6
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
93
1.83
1.51
2.0
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
44
0.00
1.51
0.0
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
108
1.76
1.50
1.4
1.1
pmol/l
302.4
267.3
—
10
76
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
86
1.86
1.50
5.4
7.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
72
1.95
1.48
12.4
13.3
mmol/l
5.7
5.3
0.49
14
72
(3023511) Choriogonadotropin [Units/volume] in Urine
28
178
1.58
1.48
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
45
317
1.42
1.47
1.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
7
28
2.50
1.45
1.4
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
377
0.64
1.43
1.0
1.0
ng/l
313.9
328.3
0.08
13
244
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
46
2.18
1.39
1.1
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
46
2.18
1.39
1.2
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
89
1.80
1.37
1.2
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
95
759
1.26
1.36
1.3
1.7
mu/l
310.7
302.7
0.10
86
698
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.94
1.36
1.2
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
21
128
1.64
1.33
1.0
1.2
%
22.7
29.0
—
6
18
(3020650) Glucose [Presence] in Urine
18
105
1.72
1.33
1.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
122
1007
1.22
1.31
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
113
1.68
1.31
1.2
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
379
0.66
1.29
1.0
1.0
ng/l
35.4
45.0
0.42
14
242
(3032057) Clostridioides difficile [Presence] in Stool
23
145
1.59
1.28
2.1
1.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
26
169
1.54
1.28
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
72
562
1.28
1.27
1.6
1.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
377
0.66
1.26
1.0
1.0
ng/l
793.7
686.3
0.85
13
236
(40757494) Bilirubin.total [Moles/volume] in Blood
42
303
1.39
1.24
2.5
2.7
umol/l
23.4
34.2
—
5
27
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
168
0.54
1.18
1.7
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
228
2007
1.14
1.16
3.1
3.3
u/ml
12013.2
1553.1
0.42
186
1714
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.6
9.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
110
1.64
1.15
1.2
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
264
2960
0.89
1.14
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
734
0.77
1.14
2.0
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
56
430
1.31
1.14
1.0
1.1
u/ml
17.3
2.6
0.78
16
143
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
137
1163
1.18
1.13
3.0
3.2
u/ml
86.2
764.0
1.96
127
1058
(3045683) HLA typing for celiac disease panel - Blood or Tissue
26
176
1.48
1.10
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
206
0.58
1.07
1.4
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
29
202
1.44
1.07
3.0
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1277
13353
0.94
1.06
3.2
3.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
194
1.45
1.06
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
205
0.58
1.06
1.4
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
40
296
1.35
1.05
2.2
2.1
ug/min
61.2
206.9
—
6
80
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
34
2.06
1.02
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
692
6497
1.07
1.01
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
256
1.37
1.00
2.5
2.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1191
12445
0.95
0.97
3.0
3.2
ug/l
0.7
0.8
2.79
853
8893
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
283
0.67
0.96
1.9
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
235
0.64
0.95
1.3
1.5
—
—
—
0
0
(3025315) Body weight
7
37
1.89
0.94
5.3
4.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
101
1.59
0.93
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
588
0.78
0.91
1.6
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
75
618
1.22
0.90
1.5
1.3
nmol/l
12.2
0.7
0.49
69
589
(3016018) Differential panel - Cerebral spinal fluid
55
438
1.26
0.89
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
145
1266
1.15
0.89
1.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
104
0.48
0.88
2.0
5.7
—
—
—
0
0
(4034850)
173
1532
1.13
0.87
13.0
11.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
62
503
1.24
0.87
1.9
1.9
g/24h
0.6
1.0
—
5
20
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
216
0.65
0.85
1.4
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
75
623
1.21
0.84
1.5
1.3
nmol/l
0.2
0.3
—
8
45
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
34
256
1.33
0.84
1.1
1.1
mg/l
279.0
295.5
0.25
29
219
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
110
949
1.16
0.81
1.1
1.2
mmol/l
3.8
3.9
0.39
101
879
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
58
1.73
0.79
1.7
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
58
1.73
0.79
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
175
0.63
0.78
1.4
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
82
1.59
0.78
1.1
1.1
u/ml
1.2
52.9
—
8
35
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
225
1.34
0.77
1.4
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
127
1443
0.88
0.75
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
35
270
1.30
0.75
1.2
1.1
mg/l
51.0
44.4
0.32
28
221
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
197
1783
1.11
0.72
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
241
2204
1.10
0.72
2.4
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
123
1083
1.14
0.71
1.2
1.3
mg/l
740.2
547.8
0.40
112
1017
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
77
654
1.18
0.71
3.2
3.8
u/ml
27.6
32.1
0.33
72
633
(3025130) Human papilloma virus identified in Specimen
36
284
1.27
0.67
1.9
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
168
0.65
0.67
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.8
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
167
0.66
0.65
1.3
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
78
1.54
0.65
2.1
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
224
1.30
0.64
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
146
1.37
0.63
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
644
0.84
0.63
3.3
4.4
umol/l
325.2
346.3
0.45
42
547
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
63
1.59
0.61
1.7
2.7
u/field
0.4
0.3
—
10
63
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
64
544
1.18
0.61
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
23
301
0.76
0.60
1.2
1.4
u/l
24.7
30.8
0.60
18
246
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
272.8
—
0
20
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
418
1.20
0.58
2.2
1.8
—
—
—
0
0
(4281824)
36
442
0.81
0.57
1.1
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
185
1.30
0.56
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
293
1.23
0.55
1.8
1.4
nmol/l
0.2
0.3
1.98
27
218
(3027008) Opiates [Presence] in Urine
63
542
1.16
0.54
2.0
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
63
544
1.16
0.52
2.0
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
241
1.25
0.52
1.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
89
789
1.13
0.52
3.6
2.4
mmol/l
4.1
4.1
0.18
89
779
(3035285) Chloride [Moles/volume] in Venous blood
89
789
1.13
0.52
3.6
2.4
mmol/l
105.3
105.7
0.25
89
779
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
152
1.32
0.52
1.1
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
109
1.38
0.50
1.7
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
30
243
1.24
0.49
3.7
6.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
189
1.27
0.49
1.0
1.1
u/l
1.1
1.1
0.91
15
99
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
144
0.69
0.49
1.6
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
87
774
1.13
0.49
3.7
2.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
45
1.56
0.48
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
272
2555
1.07
0.48
2.9
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
94
842
1.12
0.47
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
58
503
1.15
0.47
2.1
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
63
550
1.15
0.47
1.5
1.3
nmol/l
—
—
—
0
0
(3019225) pH of Specimen
571
5481
1.05
0.47
5.2
4.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
61
533
1.15
0.45
1.9
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
102
922
1.11
0.45
1.2
1.4
e6/l
84.5
966.0
3.73
78
756
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
56
487
1.15
0.45
1.8
2.1
u/field
1.7
1.7
0.01
28
175
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
86
770
1.12
0.45
2.0
1.9
pmol/l
201.6
200.4
0.04
76
716
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
223
2088
1.07
0.44
1.4
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
65
572
1.14
0.44
1.2
1.3
pmol/l
282.5
261.1
0.17
51
427
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
69
1.45
0.44
2.2
2.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
69
1.45
0.44
2.2
2.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
340
1.18
0.43
3.5
5.0
u/ml
91.8
59.9
0.23
11
94
(3036525) Urea [Moles/time] in 24 hour Urine
5
32
1.56
0.42
2.4
3.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
7.8
—
0
15
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
61
539
1.13
0.40
2.0
1.9
—
—
—
0
0
(4198724)
12
88
1.36
0.40
1.2
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
354
3380
1.05
0.39
4.2
3.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
44
381
1.16
0.39
1.6
2.0
ug/l
1.6
2.1
1.17
38
317
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
101
922
1.10
0.39
1.2
1.4
e6/l
18.7
21.3
0.08
69
721
(40761535) Cells panel - Urine sediment
465
4470
1.04
0.38
4.5
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
170
1.24
0.37
1.2
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
152
1.25
0.37
20.7
16.4
nmol/l
1407.7
1426.4
0.04
19
147
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4509
44814
1.03
0.36
5.3
5.1
mmol/l
6.1
6.1
0.47
4053
39988
(3006462) Nitrate [Presence] in Urine
30
254
1.18
0.35
4.9
4.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
117
1.28
0.35
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
108
1169
0.92
0.34
3.1
2.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
11
82
1.34
0.34
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
154
1.23
0.33
1.8
1.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
45
1.33
0.33
1.0
1.2
u/l
7.8
11.6
—
6
45
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
46
1.30
0.33
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
94
866
1.09
0.32
1.5
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
45
398
1.13
0.32
1.3
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
107
1153
0.93
0.31
6.5
3.8
mg/l
28.4
29.8
0.17
80
751
(4211845)
32
277
1.16
0.30
4.7
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4545
45678
0.98
0.29
5.4
5.3
mmol/l
2.5
2.6
9.93
4067
41213
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
68
621
1.10
0.29
1.7
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
130
1.23
0.28
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
169
1601
1.06
0.28
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
18
149
1.21
0.27
1.7
2.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
17
140
1.21
0.27
1.6
1.4
pmol/l
17.9
16.6
—
10
110
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
118
0.76
0.27
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
41
366
1.12
0.26
2.9
3.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
2.5
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
33
291
1.13
0.26
2.4
2.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4427
44478
0.98
0.25
4.9
4.7
mmol/l
4.4
4.5
6.07
3962
40336
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
114
1.23
0.25
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4385
44057
0.98
0.25
4.8
4.7
mmol/l
1.4
1.4
3.82
3896
39647
(3020874) Milk IgE Ab [Units/volume] in Serum
16
133
1.20
0.24
1.0
1.1
u/ml
0.8
2.3
—
8
44
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
44
398
1.11
0.24
1.1
1.1
—
27.8
—
0
7
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
169
0.83
0.23
1.4
2.1
e6/l
1716.2
19916.0
—
5
103
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
52
475
1.10
0.23
1.2
1.2
mmol/l
7.3
7.6
0.35
36
340
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
125
1.20
0.22
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
70
651
1.08
0.22
1.1
1.1
iu/ml
73.1
65.7
0.04
16
133
(4094501)
119
1255
0.95
0.22
1.1
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
42
1.19
0.21
1.2
4.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
2.2
2.1
umol/l
15.6
18.1
—
5
42
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
11
0.00
0.21
0.0
6.9
—
45.3
—
0
11
(3016031) Almond IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.8
—
0
6
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
2.2
—
0
12
(4133840)
8
101
0.79
0.21
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
126
1.19
0.21
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
17
145
1.17
0.20
1.5
1.7
g/l
12.6
14.7
0.38
12
114
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
420
4307
0.97
0.20
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
117
1.20
0.20
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
66
615
1.07
0.20
1.3
1.4
mu/l
51.2
59.1
0.21
58
534
(3027035) Albumin [Mass/time] in 24 hour Urine
6
48
1.25
0.20
1.8
1.3
—
640.5
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
49
1.22
0.20
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
115
0.78
0.20
1.1
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
52
1.15
0.19
14.7
10.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
268
0.90
0.17
1.5
1.4
pmol/l
60.2
165.2
—
9
86
(3051593) INR in Capillary blood by Coagulation assay
29
320
0.91
0.17
6.8
12.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
17
148
1.15
0.16
17.3
11.4
nmol/l
888.6
824.0
0.22
17
138
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
98
0.82
0.13
1.5
1.5
ng/l
183.9
159.3
—
8
98
(3037556) Urate [Mass/volume] in Serum or Plasma
19
170
1.12
0.13
1.2
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
190
0.89
0.13
1.9
2.3
e6/l
326.0
4758.6
—
10
138
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
17
190
0.89
0.13
2.0
2.2
umol/l
65.7
55.6
0.38
11
151
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2180
21926
0.99
0.12
4.8
5.4
ug/l
3.6
4.0
0.22
1888
19451
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
25
229
1.09
0.12
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
95
914
1.04
0.12
1.9
1.5
nmol/l
1.1
0.8
1.89
76
754
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
239
1.09
0.12
1.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
12
137
0.88
0.12
2.0
2.2
ug/l
1.3
1.3
0.01
12
129
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
188
1834
1.03
0.11
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
20
219
0.91
0.11
1.4
1.3
mmol/l
6.1
6.1
0.07
20
205
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
228
0.92
0.10
1.1
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
116
1.12
0.09
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
37
350
1.06
0.09
1.1
1.1
—
—
—
0
0
(4212803)
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
56
1.07
0.08
1.3
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3682
36728
1.01
0.08
41.1
22.2
g/l
329.3
331.8
50.58
3656
36353
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
176
1793
0.98
0.07
3.3
3.8
u/ml
60.7
74.6
0.35
171
1719
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
71
0.84
0.07
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
2.5
2.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
98
1.12
0.07
1.5
1.2
umol/24h
0.8
0.7
—
5
50
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
317
0.95
0.07
1.1
1.2
mmol/l
13.9
11.7
0.60
15
97
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
72
743
0.97
0.07
1.6
1.5
pmol/l
168.2
233.9
0.68
72
720
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
115
1124
1.02
0.07
2.0
1.7
mg/l
28.3
3.5
6.49
99
802
(3000034) Microalbumin [Mass/volume] in Urine
52
501
1.04
0.07
2.3
3.2
mg/l
63.4
47.0
0.25
41
385
(3002619) Bacteria identified in Specimen by Culture
8
91
0.88
0.06
1.5
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4268
42614
1.01
0.06
4.3
4.2
mmol/l
1.3
1.3
7.72
3771
37977
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
121
0.91
0.06
1.0
1.1
—
—
—
0
0
(4024509)
57
553
1.03
0.05
1.6
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
12
131
0.92
0.05
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
354
0.96
0.05
10.3
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
110
1080
1.02
0.05
1.6
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
28
293
0.96
0.05
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
101
1.09
0.04
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
141
1394
1.01
0.03
2.6
2.3
ug/min
130.0
103.2
0.37
86
812
(3033799) Differential panel - Peritoneal fluid
18
171
1.05
0.03
2.2
1.9
—
—
—
0
0
(4146454)
65
638
1.02
0.03
2.4
2.8
—
—
—
0
0
(44806420)
19
199
0.95
0.03
2.0
2.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
132
1.06
0.02
2.0
2.2
mmol/l
7.6
8.2
—
9
82
(3006270) Folate [Moles/volume] in Blood
47
478
0.98
0.01
1.1
1.2
nmol/l
295.2
337.6
0.70
36
379
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
204
1.03
0.00
1.2
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
124
0.97
0.00
1.0
1.1
u/ml
0.6
2.8
—
5
36
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
103
0.97
0.00
1.9
3.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
93
934
1.00
0.00
1.8
1.7
iu/l
4.8
4.8
0.00
26
292
(3024869) Neuronal Ab [Presence] in Serum
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
67
0.90
0.00
1.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2864.4
—
0
9
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.3
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
94
0.96
0.00
1.2
1.2
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
1364.4
—
0
9
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044336) Cobalt [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
16.6
—
0
5
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
50
1.00
0.00
2.2
1.1
umol/24h
1.9
1.8
—
5
50
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
40.0
—
0
5
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ILD – Interstitial lung disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).